COCHSTEDT INTERNATIONAL AIRPORT INC
8-K, EX-1.1, 2000-05-30
NON-OPERATING ESTABLISHMENTS
Previous: COCHSTEDT INTERNATIONAL AIRPORT INC, 8-K, 2000-05-30
Next: COCHSTEDT INTERNATIONAL AIRPORT INC, 8-K, EX-1.2, 2000-05-30



                  ACQUISITION AGREEMENT AND PLAN OF MERGER

                          DATED AS OF MAY 12, 2000

                                   BETWEEN

                             COPSIL CORPORATION

                                     AND

                    COCHSTEDT INTERNATIONAL AIRPORT, INC.

TABLE OF CONTENTS


ARTICLE 1. The Merger
  Section 1.1.                                        The Merger
  Section 1.2.                                    Effective Time
  Section 1.3.                             Closing of the Merger
  Section 1.4.                            Effects of the Merger
  Section 1.5.                  Board of Directors and Officers
  Section 1.6.                              Conversion of Shares
  Section 1.7.                          Exchange of Certificates
  Section 1.8.                                     Stock Options
  Section 1.9.        Taking of Necessary Action; Further Action

ARTICLE 2. Representations and Warranties of COPSIL
  Section 2.1.                     Organization and Qualification
  Section 2.2.                           Capitalization of COPSIL
  Section 2.3.Authority Relative to this Agreement; Recommendation.
  Section 2.4.                  SEC Reports; Financial Statements
  Section 2.5.                               Information Supplied
  Section 2.6.              Consents and Approvals; No Violations
  Section 2.7.                                         No Default
  Section 2.8.     No Undisclosed Liabilities; Absence of Changes
  Section 2.9.                                         Litigation
  Section 2.10.                    Compliance with Applicable Law
  Section 2.11.             Employee Benefit Plans; Labor Matters
  Section 2.12.                Environmental Laws and Regulations
  Section 2.13.                                       Tax Matters
  Section 2.14.                                 Title To Property
  Section 2.15.                             Intellectual Property
  Section 2.16.                                         Insurance
  Section 2.17.                                     Vote Required
  Section 2.18.                                     Tax Treatment
  Section 2.19.                                        Affiliates
  Section 2.20.                        Certain Business Practices
  Section 2.21.                                 Insider Interests
  Section 2.22.                      Opinion of Financial Adviser
  Section 2.23.                                           Brokers
  Section 2.24.                                        Disclosure
  Section 2.25.                            No Existing Discussion
  Section 2.26.                                Material Contracts

<PAGE>

ARTICLE 3. Representations and Warranties of CIA.
  Section 3.1.                     Organization and Qualification
  Section 3.2.                              Capitalization of CIA
  Section 3.3.Authority Relative to this Agreement; Recommendation
  Section 3.4.                  SEC Reports; Financial Statements
  Section 3.5.                               Information Supplied
  Section 3.6.              Consents and Approvals; No Violations
  Section 3.7.                                         No Default
  Section 3.8      No Undisclosed Liabilities; Absence of Changes
  Section 3.9.                                         Litigation
  Section 3.10.                    Compliance with Applicable Law
  Section 3.11.             Employee Benefit Plans; Labor Matters
  Section 3.12.                Environmental Laws and Regulations
  Section 3.13.                                       Tax Matters
  Section 3.14.                                 Title to Property
  Section 3.15.                             Intellectual Property
  Section 3.16.                                         Insurance
  Section 3.17.                                     Vote Required
  Section 3.18.                                     Tax Treatment
  Section 3.19.                                        Affiliates
  Section 3.20.                        Certain Business Practices
  Section 3.21.                                 Insider Interests
  Section 3.22.                      Opinion of Financial Adviser
  Section 3.23.                                           Brokers
  Section 3.24.                                        Disclosure
  Section 3.25.                           No Existing Discussions
  Section 3.26.                                Material Contracts

ARTICLE 4. Covenants
  Section 4.1.                      Conduct of Business of COPSIL
  Section 4.2.                         Conduct of Business of CIA
  Section 4.3.         Preparation of 8-K and the Proxy Statement
  Section 4.4.                         Other Potential Acquirers
  Section 4.5.                          Meetings of Stockholders
  Section 4.6.                               NASD OTC:BB Listing
  Section 4.7.                             Access to Information
  Section 4.8.        Additional Agreements; Reasonable Efforts.
  Section 4.9.Employee Benefits; Stock Option and Employee Purchase Plans
  Section 4.10.                             Public Announcements
  Section 4.11.                                  Indemnification
  Section 4.12.                  Notification of Certain Matters

ARTICLE 5. Conditions to Consummation of the Merger
            Conditions to Each Party's Obligations to Effect the
  Section 5.1.                                             Merger
  Section 5.2.            Conditions to the Obligations of COPSIL
  Section 5.3.               Conditions to the Obligations of CIA

<PAGE>

ARTICLE 6. Termination; Amendment; Waiver
  Section 6.1.                                        Termination
  Section 6.2.                              Effect of Termination
  Section 6.3.                                  Fees and Expenses
  Section 6.4.                                          Amendment
  Section 6.5.                                  Extension; Waiver

ARTICLE 7. Miscellaneous
  Section 7.1.      Nonsurvival of Representations and Warranties
  Section 7.2.                       Entire Agreement; Assignment
  Section 7.3.                                           Validity
  Section 7.4.                                            Notices
  Section 7.5.                                      Governing Law
  Section 7.6.                               Descriptive Headings
  Section 7.7.                                Parties in Interest
  Section 7.8.                               Certain Definitions
  Section 7.9.                                Personal Liability
  Section 7.10.                             Specific Performance
  Section 7.11.                                     Counterparts

<PAGE>

                        AGREEMENT AND PLAN OF MERGER

     This  Agreement and Plan of Merger (this "Agreement"), dated as  of  May
12, 2000, is between Copsil Corporation, a Nevada corporation ("COPSIL"), and
Cochstedt International Airport, Inc., a Nevada corporation ("CIA").

     Whereas,  the Boards of Directors of COPSIL and CIA each have, in  light
of  and  subject to the terms and conditions set forth herein, (i) determined
that  the  Merger (as defined below) is fair to their respective stockholders
and  in  the best interests of such stockholders and (ii) approved the Merger
in accordance with this Agreement;

     Whereas, for Federal income tax purposes, it is intended that the Merger
qualify  as  a reorganization under the provisions of Section 368(a)  of  the
Internal Revenue Code of 1986, as amended (the "Code"); and

     Whereas,   COPSIL  and  CIA  desire  to  make  certain  representations,
warranties, covenants and agreements in connection with the Merger  and  also
to prescribe various conditions to the Merger.

     Now,   therefore,   in   consideration   of   the   premises   and   the
representations, warranties, covenants and agreements herein  contained,  and
intending to be legally bound hereby, COPSIL and CIA hereby agree as follows:

                                  ARTICLE I

                                 The Merger

     Section  1.1. The Merger. At the Effective Time (as defined  below)  and
upon  the  terms  and  subject to the conditions of  this  Agreement  and  in
accordance  with  the  General Corporation Law of the state  of  Nevada  (the
"NGCL"),  CIA  shall be merged with and into COPSIL (as defined  below)  (the
''Merger).  Following  the  Merger, COPSIL shall continue  as  the  surviving
corporation  (the "Surviving Corporation"), shall continue to be governed  by
the  laws  of the jurisdiction of its incorporation or organization  and  the
separate corporate existence of CIA shall cease. Prior to the Effective Time,
the  parties  hereto  shall mutually agree as to the name  of  the  Surviving
Corporation;  however,  initially the Surviving Corporation  shall  be  named
Cochstedt  International Airport, Inc. a Nevada corporation.  The  Merger  is
intended  to qualify as a tax-free reorganization under Section  368  of  the
Code as relates to the non-cash exchange of stock referenced herein.

Section 1.2. Effective Time. Subject to the terms and conditions set forth in
this  Agreement, a Certificate of Merger (the "Merger Certificate") shall  be
duly executed and acknowledged by each of CIA and COPSIL, and thereafter  the
Merger  Certificate reflecting the Merger shall be delivered to the Secretary
of  State  of  the  State of Nevada for filing pursuant to the  NGCL  on  the
Closing  Date (as defined in Section 1.3). The Merger shall become  effective
at  such  time  as  a  properly executed and certified  copy  of  the  Merger
Certificate is duly filed by the Secretary of State of the State of Nevada in
accordance with the NGCL or such later time as the parties may agree upon and
set  forth  in  the Merger Certificate (the time at which the Merger  becomes
effective shall be referred to herein as the "Effective Time").

     Section  1.3.  Closing of the Merger. The closing  of  the  Merger  (the
"Closing")  will  take place at a time and on a date to be specified  by  the
parties,  which  shall  be  no  later than  the  second  business  day  after
satisfaction of the latest to occur of the conditions set forth in Article  5
(the  "Closing Date"), at the offices of Sperry Young & Stoecklein,  1850  E.
Flamingo  Rd.,  Suite 111, Las Vegas, Nevada, unless another  time,  date  or
place is agreed to in writing by the parties hereto.

     Section  1.4. Effects of the Merger. The Merger shall have  the  effects
set  forth in the NGCL. Without limiting the generality of the foregoing, and
subject   thereto,  at  the  Effective  Time,  all  the  properties,  rights,
privileges,  powers of CIA shall vest in the Surviving Corporation,  and  all
debts, liabilities and duties of CIA shall become the debts, liabilities  and
duties of the Surviving Corporation.

<PAGE>

     Section  1.5. Board of Directors and Officers of COPSIL. At or prior  to
the  Effective Time, each of CIA and COPSIL agrees to take such action as  is
necessary (i) to cause the number of directors comprising the full  Board  of
Directors of COPSIL to be two (2) persons and (ii) to cause Friedrich  Gradl,
and  Norbert  Doerr,  (the  "CIA Designees") to be elected  as  directors  of
COPSIL.   In addition, majority stockholders of COPSIL prior to the Effective
Time  shall  take  all  action necessary to cause,  to  the  greatest  extent
practicable, the CIA Designees to serve on COPSIL's Board of Directors  until
the 2000 Annual Meeting. If the CIA Designees, respectively, shall decline or
be  unable  to  serve as a directors prior to the Effective Time,  CIA  shall
nominate  another  person to serve in such person's stead which  such  person
shall be subject to approval of the other party. From and after the Effective
Time,  and  until successors are duly elected or appointed and  qualified  in
accordance  with  applicable  law, Friedrich Gradl  shall  be  President  and
Norbert Doerr Secretary, and Treasurer  of COPSIL.


     Section 1.6. Conversion of Shares.

     (a)  At the Effective Time, each share of common stock, par value  $.001
per  share  of  CIA  (individually a "CIA Share" and collectively,  the  "CIA
Shares")  issued  and  outstanding immediately prior to  the  Effective  Time
shall,  by  virtue of the Merger and without any action on the part  of  CIA,
COPSIL, or the holder thereof, be converted into and shall become fully  paid
and  nonassessable  COPSIL common shares determined by  multiplying  (i)  the
total  number  of  shares  of  CIA,  Three  Million  Three  Hundred  Thousand
(3,300,000) outstanding immediately prior to the Effective Time by  (ii)  Ten
(10)  (the "Exchange Ratio"), less 28,300,000 shares which shares are  to  be
issued  to  Cochstedt International Airport, Inc. and retained by  COPSIL  in
Treasury for future financing. The holder of one or more shares of CIA common
stock shall be entitled to receive in exchange therefor a number of shares of
COPSIL Common Stock equal to the product of (x) (the number of shares of  CIA
common  stock), times (y) (the Exchange Ratio. COPSIL Shares and  CIA  Shares
are  sometimes referred to collectively herein as "Shares." By way of example
the  number  of  shares  of CIA common stock held by a stockholder  (100,000)
times the Exchange Ratio of 10 equals 1,000,000 shares of COPSIL Shares to be
issued.

     (b)  At the Effective Time, each CIA Share held in the treasury of  CIA,
by CIA immediately prior to the Effective Time shall, by virtue of the Merger
and  without any action on the part of CIA or COPSIL be canceled, retired and
cease to exist and no payment shall be made with respect thereto.

     Section 1.7. Exchange of Certificates.

     (a)  Prior  to the Effective Time, COPSIL shall enter into an  agreement
with,  and shall deposit with, Sperry Young & Stoecklein, or such other agent
or  agents  as may be satisfactory to COPSIL and CIA (the "Exchange  Agent'),
for  the  benefit  of  the holders of CIA Shares, for  exchange  through  the
Exchange   Agent  in  accordance  with  this  Article  I:  (i)   certificates
representing the appropriate number of COPSIL Shares to be issued to  holders
of  CIA  Shares issuable pursuant to Section 1.6 in exchange for  outstanding
CIA Shares.

     (b)  As  soon  as reasonably practicable after the Effective  Time,  the
Exchange  Agent  shall  mail to each holder of record  of  a  certificate  or
certificates  which  immediately  prior to  the  Effective  Time  represented
outstanding CIA Shares (the "Certificates") whose shares were converted  into
the  right to receive COPSIL Shares pursuant to Section 1.6: (i) a letter  of
transmittal (which shall specify that delivery shall be effected, and risk of
loss  and  title  to the Certificates shall pass, only upon delivery  of  the
Certificates  to the Exchange Agent and shall be in such form and  have  such
other  provisions  as  CIA  and  COPSIL  may  reasonably  specify)  and  (ii)
instructions  for  use  in effecting the surrender  of  the  Certificates  in
exchange  for  certificates representing COPSIL Shares. Upon surrender  of  a
Certificate  to the Exchange Agent, together with such letter of transmittal,
duly  executed,  and  any  other  required  documents,  the  holder  of  such
Certificate  shall be entitled to receive in exchange therefor a  certificate
representing that number of whole COPSIL Shares and, if applicable,  a  check

<PAGE>

representing the cash consideration to which such holder may be  entitled  on
account of the Cash Fund, which such holder has the right to receive pursuant
to the provisions of this Article I, and the Certificate so surrendered shall
forthwith be canceled. In the event of a transfer of ownership of CIA  Shares
which  are  not  registered in the transfer records  of  CIA,  a  certificate
representing the proper number of COPSIL Shares may be issued to a transferee
if  the Certificate representing such CIA Shares is presented to the Exchange
Agent  accompanied by all documents required by the Exchange Agent or  COPSIL
to  evidence  and  effect such transfer and by evidence that  any  applicable
stock  transfer  or  other  taxes  have  been  paid.  Until  surrendered   as
contemplated  by this Section 1.7, each Certificate shall be  deemed  at  any
time  after  the Effective Time to represent only the right to  receive  upon
such surrender the certificate representing COPSIL Shares as contemplated  by
this Section 1.8.

     (c)  No  dividends  or other distributions declared or  made  after  the
Effective  Time  with respect to COPSIL Shares with a record date  after  the
Effective  Time shall be paid to the holder of any unsurrendered  Certificate
with  respect  to the COPSIL Shares represented thereby until the  holder  of
record of such Certificate shall surrender such Certificate.

     (d)  In  the event that any Certificate for CIA Shares or COPSIL  Shares
shall have been lost, stolen or destroyed, the Exchange Agent shall issue  in
exchange therefor, upon the making of an affidavit of that fact by the holder
thereof  such COPSIL Shares and cash in lieu of fractional COPSIL Shares,  if
any,  as may be required pursuant to this Agreement; provided, however,  that
COPSIL or the Exchange Agent, may, in its respective discretion, require  the
delivery of a suitable bond, opinion or indemnity.

     (e)  All  COPSIL  Shares issued upon the surrender for exchange  of  CIA
Shares  in accordance with the terms hereof (including any cash paid pursuant
to  Section 1.10 shall be deemed to have been issued in full satisfaction  of
all  rights  pertaining  to  such  CIA Shares.  There  shall  be  no  further
registration  of transfers on the stock transfer books of either  of  CIA  or
COPSIL  of the CIA Shares or COPSIL Shares which were outstanding immediately
prior  to the Effective Time. If, after the Effective Time, Certificates  are
presented  to COPSIL for any reason, they shall be canceled and exchanged  as
provided in this Article I.

     (f)  No  fractional COPSIL Shares shall be issued in the Merger, but  in
lieu  thereof  each holder of CIA Shares otherwise entitled to  a  fractional
COPSIL  Share  shall,  upon  surrender of its,  his  or  her  Certificate  or
Certificates, be entitled to receive an additional share to round up  to  the
nearest round number of shares.

     Section  1.8. At the Effective Time, each outstanding option to purchase
CIA  Shares,  if  any  (a  "CIA  Stock Option" or  collectively,  "CIA  Stock
Options")  issued  pursuant to any CIA Stock Option Plan  or  CIA  Long  Term
Incentive Plan whether vested or un-vested, shall be cancelled.

     Section 1.9. Taking of Necessary Action; Further Action. If, at any time
after the Effective Time, CIA or COPSIL reasonably determines that any deeds,
assignments,  or  instruments or confirmations of transfer are  necessary  or
desirable to carry out the purposes of this Agreement and to vest COPSIL with
full right, title and possession to all assets, property, rights, privileges,
powers  and franchises of CIA, the officers and directors of COPSIL  and  CIA
are  fully  authorized  in  the  name  of their  respective  corporations  or
otherwise  to take, and will take, all such lawful and necessary or desirable
action.

                                  ARTICLE 2

                  Representations and Warranties of COPSIL

     Except  as  set forth on the Disclosure Schedule delivered by COPSIL  to
CIA (the "COPSIL Disclosure Schedule"), COPSIL hereby represents and warrants
to CIA as follows:

     Section 2.1. Organization and Qualification.

     (a)  COPSIL  is  duly organized, validly existing and in  good  standing
under  the laws of the jurisdiction of its incorporation or organization  and
has  all  requisite  power  and  authority to  own,  lease  and  operate  its
properties  and  to  carry on its businesses as now being  conducted,  except
where  the  failure to be so organized, existing and in good standing  or  to
have  such  power and authority would not have a Material Adverse Effect  (as
defined  below)  on  COPSIL. When used in connection with  COPSIL,  the  term
"Material  Adverse  Effect" means any change or effect  (i)  that  is  or  is
reasonably  likely  to  be  materially adverse to the  business,  results  of
operations, condition (financial or otherwise) or prospects of COPSIL,  other
than  any  change  or  effect  arising out  of  general  economic  conditions
unrelated to any business in which COPSIL is engaged, or (ii) that may impair
the  ability of COPSIL to perform its obligations hereunder or to  consummate
the transactions contemplated hereby.

<PAGE>

     (b)  COPSIL has heretofore delivered to CIA accurate and complete copies
of  the  Certificate  of  Incorporation  and  Bylaws  (or  similar  governing
documents),  as  currently  in effect, of COPSIL.  Except  as  set  forth  on
Schedule  2.1 of the COPSIL Disclosure Schedule, COPSIL is duly qualified  or
licensed  and in good standing to do business in each jurisdiction  in  which
the  property  owned, leased or operated by it or the nature of the  business
conducted  by it makes such qualification or licensing necessary,  except  in
such jurisdictions where the failure to be so duly qualified or licensed  and
in good standing would not have a Material Adverse Effect on COPSIL.

     Section 2.2. Capitalization of COPSIL.

     (a)  The  authorized  capital stock of COPSIL consists  of:  (i)  Twenty
Million  (20,000,000)  Common Shares, of which, as of  March  31,  2000,  Ten
Million (10,000,000) Common Shares were issued and outstanding, and no Common
Shares  were held in treasury, (ii) Five Million (5,000,000) Preferred Shares
at  $.001  par value of which no Preferred Shares were issued or outstanding.
Concurrent  with  the Execution of the Plan of Merger, the authorized  common
stock  shall be amended to 100,000,000. All of the outstanding COPSIL  Shares
have   been  duly  authorized  and  validly  issued,  and  are  fully   paid,
nonassessable and free of preemptive rights. Except as set forth  herein,  as
of  the date hereof, there are no outstanding (i) shares of capital stock  or
other voting securities of COPSIL, (ii) securities of COPSIL convertible into
or  exchangeable for shares of capital stock or voting securities of  COPSIL,
except  for the preferred shares of COPSIL, (iii) options or other rights  to
acquire  from COPSIL and, except as described in the COPSIL SEC  Reports  (as
defined below), no obligations of COPSIL to issue, any capital stock,  voting
securities  or securities convertible into or exchangeable for capital  stock
or voting securities of COPSIL, and (iv) equity equivalents, interests in the
ownership  or  earnings  of  COPSIL or other  similar  rights  (collectively,
"COPSIL  Securities"). As of the date hereof, except as set forth on Schedule
2.2(a) of the COPSIL Disclosure Schedule there are no outstanding obligations
of  COPSIL or its subsidiaries to repurchase, redeem or otherwise acquire any
COPSIL   Securities  or  stockholder  agreements,  voting  trusts  or   other
agreements  or understandings to which COPSIL is a party or by  which  it  is
bound  relating to the voting or registration of any shares of capital  stock
of COPSIL. For purposes of this Agreement, ''Lien" means, with respect to any
asset  (including,  without  limitation, any security)  any  mortgage,  lien,
pledge,  charge, security interest or encumbrance of any kind in  respect  of
such asset.

     (b) The COPSIL Shares constitute the only class of equity securities  of
COPSIL registered or required to be registered under the Exchange Act.

     (c)  COPSIL does not own directly or indirectly more than fifty  percent
(50%) of the outstanding voting securities or interests (including membership
interests)  of  any  entity,  other than as  specifically  disclosed  in  the
disclosure documents.

     Section 2.3. Authority Relative to this Agreement; Recommendation.

     (a)  COPSIL  has all necessary corporate power and authority to  execute
and  deliver  this Agreement and to consummate the transactions  contemplated
hereby. The execution and delivery of this Agreement and the consummation  of
the transactions contemplated hereby have been duly and validly authorized by
the  Board of Directors of COPSIL (the "COPSIL Board") and no other corporate
proceedings  on the part of COPSIL are necessary to authorize this  Agreement
or to consummate the transactions contemplated hereby, except, as referred to
in  Section 2.17, the approval and adoption of this Agreement by the  holders
of  at least a majority of the then outstanding COPSIL Shares. This Agreement
has been duly and validly executed and delivered by COPSIL and constitutes  a
valid,  legal and binding agreement of COPSIL, enforceable against COPSIL  in
accordance with its terms.

     (b) The COPSIL Board has resolved to recommend that the stockholders  of
COPSIL approve and adopt this Agreement.

     Section 2.4. SEC Reports; Financial Statements.

     (a)  COPSIL has filed all required forms, reports and documents with the
Securities and Exchange Commission (the "SEC") since March 31, 2000, each  of
which  has complied in all material respects with all applicable requirements
of  the  Securities Act of 1933, as amended (the "Securities Act"),  and  the
<PAGE>

Exchange   Act  (and  the  rules  and  regulations  promulgated   thereunder,
respectively),  each  as  in  effect on the dates  such  forms,  reports  and
documents  were  filed.  COPSIL has heretofore  delivered  or  promptly  will
deliver  prior to the Effective Date to CIA, in the form filed with  the  SEC
(including any amendments thereto but excluding any exhibits), (i)  its  Form
10-KSB  for  period  ending  December 31, 1999,  (ii)  all  definitive  proxy
statements relating to COPSIL's meetings of stockholders (whether  annual  or
special) held since December 31, 1999, if any, and (iii) all other reports or
registration  statements filed by COPSIL with the SEC since  March  31,  2000
(all  of the foregoing, collectively, the "COPSIL SEC Reports"). None of such
COPSIL  SEC  Reports, including, without limitation, any financial statements
or  schedules included or incorporated by reference therein, contained,  when
filed, any untrue statement of a material fact or omitted to state a material
fact  required to be stated or incorporated by reference therein or necessary
in  order to make the statements therein, in light of the circumstances under
which  they  were made, not misleading. The audited financial  statements  of
COPSIL included in the COPSIL SEC Reports fairly present, in conformity  with
generally  accepted  accounting  principles applied  on  a  consistent  basis
(except as may be indicated in the notes thereto), the financial position  of
COPSIL  as of the dates thereof and its results of operations and changes  in
financial  position  for  the periods then ended.  All  material  agreements,
contracts and other documents required to be filed as exhibits to any of  the
COPSIL SEC Reports have been so filed.

     (b) COPSIL has heretofore made available or promptly will make available
to  CIA a complete and correct copy of any amendments or modifications  which
are  required to be filed with the SEC but have not yet been filed  with  the
SEC,  to agreements, documents or other instruments which previously had been
filed by COPSIL with the SEC pursuant to the Exchange Act.

     Section  2.5. Information Supplied. None of the information supplied  or
to  be  supplied  by COPSIL for inclusion or incorporation  by  reference  in
connection with the Merger (the "Proxy Statement") will at the date mailed to
stockholders  of  COPSIL  and  at the times of the  meeting  or  meetings  of
stockholders of COPSIL to be held in connection with the Merger, contain  any
untrue  statement  of  a  material fact or omit to state  any  material  fact
required  to  be stated therein or necessary in order to make the  statements
therein,  in  light  of  the circumstances under which  they  are  made,  not
misleading.  The  Proxy Statement, insofar as it relates to  the  meeting  of
COPSIL's  stockholders to vote on the Merger, will comply as to form  in  all
material  respects with the provisions of the Exchange Act and the rules  and
regulations thereunder.

     Section  2.6. Consents and Approvals; No Violations. Except for filings,
permits, authorizations, consents and approvals as may be required under, and
other applicable requirements of, the Securities Act, the Exchange Act, state
securities or blue sky laws, the Hart-Scott-Rodino Antitrust Improvements Act
of  1916, as amended (the ''HSR Act''), the rules of the National Association
of  Securities  Dealers,  Inc. ("NASD"), the filing and  recordation  of  the
Merger Certificate as required by the NGCL, and as set forth on Schedule  2.6
of the COPSIL Disclosure Schedule no filing with or notice to, and no permit,
authorization,   consent  or  approval  of,  any   court   or   tribunal   or
administrative,  governmental  or regulatory body,  agency  or  authority  (a
"Governmental Entity") is necessary for the execution and delivery by  COPSIL
of  this  Agreement  or  the  consummation  by  COPSIL  of  the  transactions
contemplated  hereby,  except  where the  failure  to  obtain  such  permits,
authorizations, consents or approvals or to make such filings  or  give  such
notice would not have a Material Adverse Effect on COPSIL.

     Except  as  set forth in Section 2.6 of the COPSIL Disclosure  Schedule,
neither  the execution, delivery and performance of this Agreement by  COPSIL
nor  the consummation by COPSIL of the transactions contemplated hereby  will
(i)  conflict with or result in any breach of any provision of the respective
Certificate  of Incorporation or Bylaws (or similar governing  documents)  of
COPSIL,  (ii)  result  in a violation or breach of, or  constitute  (with  or
without due notice or lapse of time or both) a default (or give rise  to  any
right of termination, amendment, cancellation or acceleration or Lien) under,
any  of  the  terms,  conditions or provisions of any note,  bond,  mortgage,
indenture,  lease,  license,  contract,  agreement  or  other  instrument  or
obligation  to  which COPSIL is a party or by which any of its properties  or
assets  may  be bound, or (iii) violate any order, writ, injunction,  decree,
law,  statute,  rule  or  regulation applicable  to  COPSIL  or  any  of  its
properties  or  assets, except in the case of (ii) or (iii)  for  violations,
breaches  or  defaults  which  would not have a Material  Adverse  Effect  on
COPSIL.

     Section  2.7.  No  Default. Except as set forth in Section  2.7  of  the
COPSIL  Disclosure  Schedule, COPSIL is not in breach, default  or  violation
(and  no  event has occurred which with notice or the lapse of time  or  both
would  constitute  a breach default or violation) of any term,  condition  or
provision  of  (i)  its Certificate of Incorporation or  Bylaws  (or  similar
governing  documents),  (ii)  any  note, bond,  mortgage,  indenture,  lease,
<PAGE>

license,  contract,  agreement or other instrument  or  obligation  to  which
COPSIL  is now a party or by which any of its respective properties or assets
may  be bound or (iii) any order, writ injunction, decree, law, statute, rule
or  regulation  applicable to COPSIL or any of its respective  properties  or
assets,  except  in  the  case of (ii) or (iii) for violations,  breaches  or
defaults  that would not have a Material Adverse Effect on COPSIL. Except  as
set  forth in Section 2.7 of the COPSIL Disclosure Schedule, each note, bond,
mortgage,  indenture, lease, license, contract, agreement or other instrument
or  obligation  to  which COPSIL is now a party or by  which  its  respective
properties or assets may be bound that is material to COPSIL and that has not
expired  is  in  full  force and effect and is not subject  to  any  material
default thereunder of which COPSIL is aware by any party obligated to  COPSIL
thereunder.

     Section  2.8. No Undisclosed Liabilities; Absence of Changes. Except  as
set  forth in Section 2.8 of the COPSIL Disclosure Schedule and except as and
to  the extent publicly disclosed by COPSIL in the COPSIL SEC Reports, as  of
March  31, 2000, COPSIL does not have any liabilities or obligations  of  any
nature,  whether  or  not  accrued, contingent or otherwise,  that  would  be
required  by  generally accepted accounting principles to be reflected  on  a
balance sheet of COPSIL (including the notes thereto) or which would  have  a
Material  Adverse Effect on COPSIL. Except as publicly disclosed  by  COPSIL,
since  March 31, 2000, COPSIL has not incurred any liabilities of any nature,
whether  or  not accrued, contingent or otherwise, which could reasonably  be
expected  to  have, and there have been no events, changes  or  effects  with
respect  to  COPSIL having or which reasonably could be expected to  have,  a
Material  Adverse  Effect on COPSIL. Except as and  to  the  extent  publicly
disclosed  by  COPSIL in the COPSIL SEC Reports and except as  set  forth  in
Section  2.8  of the COPSIL Disclosure Schedule, since March 31, 2000,  there
has  not  been  (i) any material change by COPSIL in its accounting  methods,
principles  or  practices (other than as required after the  date  hereof  by
concurrent  changes  in generally accepted accounting principles),  (ii)  any
revaluation  by COPSIL of any of its assets having a Material Adverse  Effect
on  COPSIL, including, without limitation, any write-down of the value of any
assets  other  than  in the ordinary course of business or  (iii)  any  other
action  or  event  that would have required the consent of  any  other  party
hereto  pursuant  to Section 4.1 of this Agreement had such action  or  event
occurred after the date of this Agreement.

     Section 2.9. Litigation. Except as publicly disclosed by COPSIL  in  the
COPSIL  SEC  Reports,  there  is  no  suit,  claim,  action,  proceeding   or
investigation  pending  or,  to the knowledge of COPSIL,  threatened  against
COPSIL  or  any of its subsidiaries or any of their respective properties  or
assets  before  any  Governmental  Entity  which,  individually  or  in   the
aggregate, could reasonably be expected to have a Material Adverse Effect  on
COPSIL  or  could reasonably be expected to prevent or delay the consummation
of  the  transactions  contemplated by this  Agreement.  Except  as  publicly
disclosed by COPSIL in the COPSIL SEC Reports, COPSIL is not subject  to  any
outstanding  order,  writ,  injunction or decree which,  insofar  as  can  be
reasonably  foreseen in the future, could reasonably be expected  to  have  a
Material Adverse Effect on COPSIL or could reasonably be expected to  prevent
or delay the consummation of the transactions contemplated hereby.

     Section  2.10.  Compliance  with  Applicable  Law.  Except  as  publicly
disclosed  by  COPSIL in the COPSIL SEC Reports, COPSIL  holds  all  permits,
licenses,  variances, exemptions, orders and approvals  of  all  Governmental
Entities necessary for the lawful conduct of their respective businesses (the
`'COPSIL  Permits"),  except  for failures to hold  such  permits,  licenses,
variances,  exemptions, orders and approvals which would not have a  Material
Adverse  Effect  on COPSIL. Except as publicly disclosed  by  COPSIL  in  the
COPSIL  SEC  Reports, COPSIL is in compliance with the terms  of  the  COPSIL
Permits,  except  where the failure so to comply would not  have  a  Material
Adverse  Effect  on COPSIL. Except as publicly disclosed  by  COPSIL  in  the
COPSIL  SEC  Reports,  the  business of COPSIL  is  not  being  conducted  in
violation  of  any  law, ordinance or regulation of any  Governmental  Entity
except  that no representation or warranty is made in this Section 2.10  with
respect  to Environmental Laws (as defined in Section 2.12 below) and  except
for  violations  or  possible  violations  which  do  not,  and,  insofar  as
reasonably  can be foreseen, in the future will not, have a Material  Adverse
Effect  on  COPSIL. Except as publicly disclosed by COPSIL in the COPSIL  SEC
Reports,  no investigation or review by any Governmental Entity with  respect
to  COPSIL is pending or, to the knowledge of COPSIL, threatened, nor, to the
knowledge  of  COPSIL, has any Governmental Entity indicated an intention  to
conduct  the  same,  other than, in each case, those which COPSIL  reasonably
believes will not have a Material Adverse Effect on COPSIL.

     Section 2.11. Employee Benefit Plans; Labor Matters.

     (a)  Except  as  set  forth in Section 2.11(a) of the COPSIL  Disclosure
Schedule  with  respect  to  each  employee benefit  plan,  program,  policy,
arrangement  and  contract  (including,  without  limitation,  any  "employee

<PAGE>

benefit  plan," as defined in Section 3(3) of the Employee Retirement  Income
Security Act of 1974, as amended ("ERISA")), maintained or contributed to  at
any  time  by  COPSIL  or  any entity required to be aggregated  with  COPSIL
pursuant  to  Section  414 of the Code (each, a "COPSIL Employee  Plan"),  no
event  has  occurred and to the knowledge of COPSIL, no condition or  set  of
circumstances  exists  in connection with which COPSIL  could  reasonably  be
expected  to be subject to any liability which would have a Material  Adverse
Effect on COPSIL.

     (b)  (i) No COPSIL Employee Plan is or has been subject to Title  IV  of
ERISA or Section 412 of the Code; and (ii) each COPSIL Employee Plan intended
to  qualify  under  Section 401(a) of the Code and  each  trust  intended  to
qualify  under  Section  501(a) of the Code is the  subject  of  a  favorable
Internal Revenue Service determination letter, and nothing has occurred which
could reasonably be expected to adversely affect such determination.

     (c)  Section 2.11(c) of the COPSIL Disclosure Schedule sets forth a true
and complete list, as of the date of this Agreement, of each person who holds
any COPSIL Stock Options, together with the number of COPSIL Shares which are
subject to such option, the date of grant of such option, the extent to which
such option is vested (or will become vested as a result of the Merger),  the
option price of such option (to the extent determined as of the date hereof),
whether  such option is a nonqualified stock option or is intended to qualify
as  an  incentive stock option within the meaning of Section  422(b)  of  the
Code,  and the expiration date of such option. Section 2.11(c) of the  COPSIL
Disclosure Schedule also sets forth the total number of such incentive  stock
options and such nonqualified options. COPSIL has furnished CIA with complete
copies  of the plans pursuant to which the COPSIL Stock Options were  issued.
Other  than  the  automatic vesting of COPSIL Stock Options  that  may  occur
without any action on the part of COPSIL or its officers or directors, COPSIL
has  not taken any action that would result in any COPSIL Stock Options  that
are  unvested  becoming  vested in connection with or  as  a  result  of  the
execution  and  delivery  of  this  Agreement  or  the  consummation  of  the
transactions contemplated hereby.

     (d)  COPSIL has made available to CIA (i) a description of the terms  of
employment and compensation arrangements of all officers of COPSIL and a copy
of  each  such  agreement currently in effect; (ii) copies of all  agreements
with  consultants who are individuals obligating COPSIL to make  annual  cash
payments  in  an  amount  exceeding $60,000; (iii)  a  schedule  listing  all
officers of COPSIL who have executed a non-competition agreement with  COPSIL
and  a  copy  of  each such agreement currently in effect;  (iv)  copies  (or
descriptions)  of all severance agreements, programs and policies  of  COPSIL
with  or relating to its employees, except programs and policies required  to
be  maintained by law; and (v) copies of all plans, programs, agreements  and
other  arrangements of COPSIL with or relating to its employees which contain
change in control provisions all of which are set forth in Section 2.11(d) of
the COPSIL Disclosure Schedule.

     (e)   There  shall  be  no  payment,  accrual  of  additional  benefits,
acceleration of payments, or vesting in any benefit under any COPSIL Employee
Plan or any agreement or arrangement disclosed under this Section 2.11 solely
by   reason   of  entering  into  or  in  connection  with  the  transactions
contemplated by this Agreement.

     (f)  There are no controversies pending or, to the knowledge of  COPSIL,
threatened,  between  COPSIL and any of their employees, which  controversies
have  or  could reasonably be expected to have a Material Adverse  Effect  on
COPSIL.  Neither  COPSIL  nor  any of its subsidiaries  is  a  party  to  any
collective  bargaining agreement or other labor union contract applicable  to
persons employed by COPSIL or any of its subsidiaries (and neither COPSIL nor
any  of  its subsidiaries has any outstanding material liability with respect
to  any  terminated collective bargaining agreement or labor union contract),
nor  does COPSIL know of any activities or proceedings of any labor union  to
organize  any  of its or employees. COPSIL has no knowledge  of  any  strike,
slowdown, work stoppage, lockout or threat thereof, by or with respect to any
of its employees.

     Section 2.12. Environmental Laws and Regulations.

     (a)  Except  as publicly disclosed by COPSIL in the COPSIL SEC  Reports,
(i)  COPSIL  is  in material compliance with all applicable  federal,  state,
local and foreign laws and regulations relating to pollution or protection of
human health or the environment (including, without limitation, ambient  air,
surface   water,   ground   water,  land  surface   or   subsurface   strata)
(collectively,  "Environmental Laws"), except for non-compliance  that  would

<PAGE>

not  have a Material Adverse Effect on COPSIL, which compliance includes, but
is not limited to, the possession by COPSIL of all material permits and other
governmental authorizations required under applicable Environmental Laws, and
compliance  with  the  terms  and conditions thereof;  (ii)  COPSIL  has  not
received  written notice of, or, to the knowledge of COPSIL, is  the  subject
of,  any  action, cause of action, claim, investigation, demand or notice  by
any  person  or  entity alleging liability under or non-compliance  with  any
Environmental  Law  (an  ''Environmental Claim")  that  could  reasonably  be
expected  to  have  a Material Adverse Effect on COPSIL;  and  (iii)  to  the
knowledge of COPSIL, there are no circumstances that are reasonably likely to
prevent or interfere with such material compliance in the future.

     (b)  Except  as publicly disclosed by COPSIL, there are no Environmental
Claims  which could reasonably be expected to have a Material Adverse  Effect
on COPSIL that are pending or, to the knowledge of COPSIL, threatened against
COPSIL  or,  to the knowledge of COPSIL, against any person or  entity  whose
liability  for  any Environmental Claim COPSIL has or may  have  retained  or
assumed either contractually or by operation of law.

     Section 2.13. Tax Matters.

     (a)  Except  as  set  forth  in Section 2.13 of  the  COPSIL  Disclosure
Schedule:  (i) COPSIL has filed or has had filed on its behalf  in  a  timely
manner  (within  any  applicable  extension  periods)  with  the  appropriate
Governmental  Entity  all income and other material Tax Returns  (as  defined
herein)  with  respect to Taxes (as defined herein) of  COPSIL  and  all  Tax
Returns  were in all material respects true, complete and correct;  (ii)  all
material  Taxes with respect to COPSIL have been paid in full  or  have  been
provided  for  in accordance with GAAP on COPSIL's most recent balance  sheet
which  is  part  of the COPSIL SEC Documents. (iii) there are no  outstanding
agreements   or  waivers  extending  the  statutory  period  of   limitations
applicable  to any federal, state, local or foreign income or other  material
Tax  Returns required to be filed by or with respect to COPSIL; (iv)  to  the
knowledge  of COPSIL none of the Tax Returns of or with respect to COPSIL  is
currently  being audited or examined by any Governmental Entity; and  (v)  no
deficiency  for  any  income or other material Taxes has been  assessed  with
respect to COPSIL which has not been abated or paid in full.

     (b)  For  purposes of this Agreement, (i) "Taxes" shall mean all  taxes,
charges,  fees,  levies or other assessments, including, without  limitation,
income,  gross receipts, sales, use, ad valorem, goods and services, capital,
transfer,  franchise,  profits,  license, withholding,  payroll,  employment,
employer health, excise, estimated, severance, stamp, occupation, property or
other  taxes,  customs  duties, fees, assessments  or  charges  of  any  kind
whatsoever, together with any interest and any penalties, additions to tax or
additional  amounts  imposed by any taxing authority and  (ii)  "Tax  Return"
shall mean any report, return, documents declaration or other information  or
filing  required to be supplied to any taxing authority or jurisdiction  with
respect to Taxes.

     Section 2.14. Title to Property. COPSIL has good and defensible title to
all  of  its properties and assets, free and clear of all liens, charges  and
encumbrances except liens for taxes not yet due and payable and such liens or
other  imperfections of title, if any, as do not materially detract from  the
value  of or interfere with the present use of the property affected  thereby
or which, individually or in the aggregate, would not have a Material Adverse
Effect  on COPSIL; and, to COPSIL's knowledge, all leases pursuant  to  which
COPSIL  leases  from others real or personal property are in  good  standing,
valid  and effective in accordance with their respective terms, and there  is
not,  to  the  knowledge of COPSIL, under any of such  leases,  any  existing
material default or event of default (or event which with notice of lapse  of
time, or both, would constitute a default and in respect of which COPSIL  has
not  taken  adequate steps to prevent such a default from  occurring)  except
where  the  lack  of such good standing, validity and effectiveness,  or  the
existence of such default or event, would not have a Material Adverse  Effect
on COPSIL.

     Section 2.15. Intellectual Property.

     (a) COPSIL owns, or possesses adequate licenses or other valid rights to
use, all existing United States and foreign patents, trademarks, trade names,
service  marks, copyrights, trade secrets and applications therefor that  are
material  to  its  business as currently conducted (the "COPSIL  Intellectual
Property Rights").

     (b)  The  validity of the COPSIL Intellectual Property  Rights  and  the
title  thereto of COPSIL is not being questioned in any litigation  to  which
COPSIL is a party.

     (c)  Except  as  set  forth in Section 2.15(c) of the COPSIL  Disclosure
Schedule, the conduct of the business of COPSIL as now conducted does not, to
COPSIL's  knowledge,  infringe any valid patents,  trademarks,  trade  names,
<PAGE>
service  marks or copyrights of others. The consummation of the  transactions
completed  hereby  will not result in the loss or impairment  of  any  COPSIL
Intellectual Property Rights.

     (d)  COPSIL  has  taken  steps it believes appropriate  to  protect  and
maintain its trade secrets as such, except in cases where COPSIL has  elected
to rely on patent or copyright protection in lieu of trade secret protection.

     Section  2.16.  Insurance. COPSIL currently does  not  maintain  general
liability and other business insurance.

     Section 2.17. Vote Required. The affirmative vote of the holders  of  at
least  a  majority of the outstanding COPSIL Shares is the only vote  of  the
holders of any class or series of COPSIL's capital stock necessary to approve
and adopt this Agreement and the Merger.

     Section  2.18.  Tax Treatment. Neither COPSIL nor, to the  knowledge  of
COPSIL,  any of its affiliates has taken or agreed to take action that  would
prevent  the Merger from constituting a reorganization qualifying  under  the
provisions of Section 368(a) of the Code.

     Section  2.19.  Affiliates.  Except  for  Principal  COPSIL  Stockholder
("PVS")  and the directors and executive officers of COPSIL, each of whom  is
listed  in  Section  2.19  of the COPSIL Disclosure Schedule,  there  are  no
persons  who,  to the knowledge of COPSIL, may be deemed to be affiliates  of
COPSIL  under  Rule  1-02(b)  of Regulation  S-X  of  the  SEC  (the  "COPSIL
Affiliates").

     Section  2.20.  Certain  Business  Practices.  None  of  COPSIL  or  any
directors, officers, agents or employees of COPSIL has (i) used any funds for
unlawful  contributions,  gifts, entertainment  or  other  unlawful  expenses
relating to political activity, (ii) made any unlawful payment to foreign  or
domestic  government  officials  or  employees  or  to  foreign  or  domestic
political  parties  or  campaigns or violated any provision  of  the  Foreign
Corrupt  Practices Act of 1977, as amended (the "FCPA"), or  (iii)  made  any
other unlawful payment.

     Section 2.21. Insider Interests. Except as set forth in Section 2.21  of
the  COPSIL  Disclosure Schedule, neither PVS nor any officer or director  of
COPSIL  has any interest in any material property, real or personal, tangible
or  intangible, including without limitation, any computer software or COPSIL
Intellectual  Property  Rights,  used in or pertaining  to  the  business  of
COPSIL,  expect  for the ordinary rights of a stockholder or  employee  stock
option holder.

     Section 2.22. Opinion of Financial Adviser. No advisers, as of the  date
hereof,  have delivered to the COPSIL Board a written opinion to  the  effect
that, as of such date, the exchange ratio contemplated by the Merger is  fair
to the holders of COPSIL Shares.

     Section  2.23.  Brokers. No broker, finder or investment  banker  (other
than  the  COPSIL  Financial  Adviser, a  true  and  correct  copy  of  whose
engagement  agreement has been provided to CIA) is entitled to any brokerage,
finder's  or  other  fee  or commission in connection with  the  transactions
contemplated by this Agreement based upon arrangements made by or  on  behalf
of COPSIL.

     Section  2.24. Disclosure. No representation or warranty  of  COPSIL  in
this  Agreement  or any certificate, schedule, document or  other  instrument
furnished or to be furnished to CIA pursuant hereto or in connection herewith
contains,  as of the date of such representation, warranty or instrument,  or
will contain any untrue statement of a material fact or, at the date thereof,
omits  or  will omit to state a material fact necessary to make any statement
herein  or  therein, in light of the circumstances under which such statement
is or will be made, not misleading.

     Section 2.25. No Existing Discussions. As of the date hereof, COPSIL  is
not  engaged, directly or indirectly, in any discussions or negotiations with
any  other  party with respect to any Third Party Acquisition (as defined  in
Section 4.4).

     Section 2.26. Material Contracts.

     (a)  COPSIL  has  delivered or otherwise made  available  to  CIA  true,
correct  and  complete  copies  of  all contracts  and  agreements  (and  all
<PAGE>
amendments,  modifications and supplements thereto and all  side  letters  to
which COPSIL is a party affecting the obligations of any party thereunder) to
which COPSIL is a party or by which any of its properties or assets are bound
that are, material to the business, properties or assets of COPSIL taken as a
whole, including, without limitation, to the extent any of the following are,
individually  or  in the aggregate, material to the business,  properties  or
assets  of  COPSIL taken as a whole, all: (i) employment, product  design  or
development,  personal  services,  consulting,  non-competition,   severance,
golden parachute or indemnification contracts (including, without limitation,
any  contract to which COPSIL is a party involving employees of COPSIL); (ii)
licensing,  publishing,  merchandising  or  distribution  agreements;   (iii)
contracts  granting  rights  of  first refusal  or  first  negotiation;  (iv)
partnership  or joint venture agreements; (v) agreements for the acquisition,
sale  or lease of material properties or assets or stock or otherwise entered
into since March 31, 2000; (vi) contracts or agreements with any Governmental
Entity.  and (vii) all commitments and agreements to enter into  any  of  the
foregoing  (collectively, together with any such contracts  entered  into  in
accordance with Section 4.1 hereof, the "COPSIL Contracts"). COPSIL is not  a
party to or bound by any severance, golden parachute or other agreement  with
any employee or consultant pursuant to which such person would be entitled to
receive any additional compensation or an accelerated payment of compensation
as a result of the consummation of the transactions contemplated hereby.

     (b)  Each of the COPSIL Contracts is valid and enforceable in accordance
with  its terms, and there is no default under any COPSIL Contract so  listed
either  by COPSIL or, to the knowledge of COPSIL, by any other party thereto,
and no event has occurred that with the lapse of time or the giving of notice
or  both would constitute a default thereunder by COPSIL or, to the knowledge
of  COPSIL, any other party, in any such case in which such default or  event
could reasonably be expected to have a Material Adverse Effect on COPSIL.

     (c)  No party to any such COPSIL Contract has given notice to COPSIL  of
or  made  a  claim  against  COPSIL with respect to  any  breach  or  default
thereunder, in any such case in which such breach or default could reasonably
be expected to have a Material Adverse Effect on COPSIL.

                                  ARTICLE 3

                    Representations and Warranties of CIA

     Except  as  set  forth on the Disclosure Schedule delivered  by  CIA  to
COPSIL (the "CIA Disclosure Schedule"), CIA hereby represents and warrants to
COPSIL as follows:

     Section 3.1. Organization and Qualification.

     (a) Each of CIA and its subsidiaries is duly organized, validly existing
and  in good standing under the laws of the jurisdiction of its incorporation
or  organization and has all requisite power and authority to own, lease  and
operate its properties and to carry on its businesses as now being conducted,
except where the failure to be so organized, existing and in good standing or
to have such power and authority would not have a Material Adverse Effect (as
defined  below) on CIA. When used in connection with CIA, the term  "Material
Adverse  Effect''  means any change or effect (i) that is  or  is  reasonably
likely  to  be  materially adverse to the business,  results  of  operations,
condition  (financial or otherwise) or prospects of CIA and its subsidiaries,
taken  as  a  whole, other than any change or effect arising out  of  general
economic  conditions  unrelated  to any  businesses  in  which  CIA  and  its
subsidiaries  are  engaged, or (ii) that may impair the  ability  of  CIA  to
consummate the transactions contemplated hereby.

     (b)  CIA has heretofore delivered to COPSIL accurate and complete copies
of  the  Certificate  of  Incorporation  and  Bylaws  (or  similar  governing
documents),  as currently in effect, of CIA. Each of CIA and its subsidiaries
is  duly  qualified or licensed and in good standing to do business  in  each
jurisdiction  in which the property owned, leased or operated by  it  or  the
nature  of the business conducted by it makes such qualification or licensing
necessary  except  in  such jurisdictions where the failure  to  be  so  duly
qualified or licensed and in good standing would not have a Material  Adverse
Effect on CIA.

     Section 3.2. Capitalization of CIA.

     (a)  As  of March 31, 2000, the authorized capital stock of CIA consists
of;  (i) Twenty-Five Million (25,000,000) CIA common Shares, $.001 par value,
<PAGE>

3,300,000  common  Shares  were  issued and were  outstanding,  and  (ii)  no
preferred shares were authorized. All of the outstanding CIA Shares have been
duly  authorized  and validly issued, and are fully paid,  nonassessable  and
free of preemptive rights.

     (b)  Except  as  set  forth  in Section 3.2(b)  of  the  CIA  Disclosure
Schedule,  CIA  is the record and beneficial owner of all of the  issued  and
outstanding shares of capital stock of its subsidiaries.

     (c)  Except  as  set  forth  in Section 3.2(c)  of  the  CIA  Disclosure
Schedule,  between  March 31, 2000 and the date hereof, no  shares  of  CIA's
capital  stock  have been issued and no CIA Stock options have been  granted.
Except as set forth in Section 3.2(a) above, as of the date hereof, there are
no outstanding (i) shares of capital stock or other voting securities of CIA,
(ii)  securities of CIA or its subsidiaries convertible into or  exchangeable
for  shares  of capital stock or voting securities of CIA, (iii)  options  or
other  rights to acquire from CIA or its subsidiaries, or obligations of  CIA
or  its  subsidiaries  to  issue, any capital  stock,  voting  securities  or
securities  convertible  into or exchangeable for  capital  stock  or  voting
securities of CIA, or (iv) equity equivalents, interests in the ownership  or
earnings  of  CIA or its subsidiaries or other similar rights  (collectively,
"CIA   Securities").  As  of  the  date  hereof,  there  are  no  outstanding
obligations  of  CIA  or  any of its subsidiaries to  repurchase,  redeem  or
otherwise  acquire  any CIA Securities. There are no stockholder  agreements,
voting  trusts or other agreements or understandings to which CIA is a  party
or  by which it is bound relating to the voting or registration of any shares
of capital stock of CIA.

     (d)  Except  as  set  forth  in Section 3.2(d)  of  the  CIA  Disclosure
Schedule,  there  are no securities of CIA convertible into  or  exchangeable
for,  no  options or other rights to acquire from CIA, and no other contract,
understanding,   arrangement  or  obligation  (whether  or  not   contingent)
providing  for the issuance or sale, directly or indirectly, of  any  capital
stock  or  other  ownership  interests in, or any other  securities  of,  any
subsidiary of CIA.

     (e) The CIA Shares constitute the only class of equity securities of CIA
or its subsidiaries.

     (f)  Except  as  set  forth  in Section 3.2(f)  of  the  CIA  Disclosure
Schedule,  CIA  does not own directly or indirectly more than  fifty  percent
(50%) of the outstanding voting securities or interests (including membership
interests) of any entity.

     Section 3.3. Authority Relative to this Agreement; Recommendation.

     (a)  CIA has all necessary corporate power and authority to execute  and
deliver  this  Agreement  and  to  consummate the  transactions  contemplated
hereby. The execution and delivery of this Agreement and the consummation  of
the transactions contemplated hereby have been duly and validly authorized by
the  Board  of  Directors of CIA (the "CIA Board"), and  no  other  corporate
proceedings  on the part of CIA are necessary to authorize this Agreement  or
to consummate the transactions contemplated hereby, except, as referred to in
Section  3.17, the approval and adoption of this Agreement by the holders  of
at  least  a majority of the then outstanding CIA Shares. This Agreement  has
been  duly and validly executed and delivered by CIA and constitutes a valid,
legal  and  binding agreement of CIA, enforceable against CIA  in  accordance
with its terms.

     (b) The CIA Board has resolved to recommend that the stockholders of CIA
approve and adopt this Agreement.

     Section  3.4. SEC Reports; Financial Statements. CIA is not required  to
file forms, reports and documents with the SEC.

     Section  3.5. Information Supplied. None of the information supplied  or
to  be supplied by CIA for inclusion or incorporation by reference to (i) the
8-K  will,  at  the time the 8-K is filed with the SEC and  at  the  time  it
becomes effective under the Securities Act, contain any untrue statement of a
material  fact  or  omit  to state any material fact required  to  be  stated
therein  or necessary to make the statements therein not misleading and  (ii)
the  Proxy  Statement will, at the date mailed to stockholders of COPSIL,  if
any, and at the times of the meeting or meetings of stockholders of COPSIL to
be  held  in  connection with the Merger, contain any untrue statement  of  a
material  fact  or  omit  to state any material fact required  to  be  stated
therein or necessary in order to make the statements therein, in light of the
<PAGE>

circumstances under which they are made, not misleading. The Proxy Statement,
insofar  as  it relates to the meeting of CIA's stockholders to vote  on  the
Merger,  will comply as to form in all material respects with the  provisions
of  the  Exchange Act and the rules and regulations thereunder, and  the  8-K
will  comply as to form in all material respects with the provisions  of  the
Securities Act and the rules and regulations thereunder.

     Section 3.6. Consents and Approvals; No Violations. Except as set  forth
in  Section  3.6  of  the CIA Disclosure Schedule, and for filings,  permits,
authorizations,  consents and approvals as may be required under,  and  other
applicable  requirements  of, the Securities Act,  the  Exchange  Act,  state
securities  or  blue sky laws, the HSR Act, the rules of the  NASD,  and  the
filing and recordation of the Merger Certificate as required by the NGCL,  no
filing  with or notice to, and no permit, authorization, consent or  approval
of,  any  Governmental Entity is necessary for the execution and delivery  by
CIA  of  this  Agreement  or  the consummation by  CIA  of  the  transactions
contemplated  hereby,  except  where the  failure  to  obtain  such  permits,
authorizations  consents or approvals or to make such filings  or  give  such
notice would not have a Material Adverse Effect on CIA.

     Neither the execution, delivery and performance of this Agreement by CIA
nor  the consummation by CIA of the transactions contemplated hereby will (i)
conflict  with  or  result in any breach of any provision of  the  respective
Certificate  of Incorporation or Bylaws (or similar governing  documents)  of
CIA or any of CIA's subsidiaries, (ii) result in a violation or breach of, or
constitute  (with or without due notice or lapse of time or both)  a  default
(or  give  rise  to  any  right  of termination, amendment,  cancellation  or
acceleration  or Lien) under, any of the terms, conditions or  provisions  of
any  note, bond, mortgage, indenture, lease, license, contract, agreement  or
other instrument or obligation to which CIA or any of CIAis subsidiaries is a
party or by which any of them or any of their respective properties or assets
may  be  bound  or  (iii) violate any order, writ, injunction,  decree,  law,
statute, rule or regulation applicable to CIA or any of CIA's subsidiaries or
any  of their respective properties or assets, except in the case of (ii)  or
(iii)  for  violations, breaches or defaults which would not have a  Material
Adverse Effect on CIA.

     Section  3.7. No Default. None of CIA or any of its subsidiaries  is  in
breach, default or violation (and no event has occurred which with notice  or
the lapse of time or both would constitute a breach, default or violation) of
any  term, condition or provision of (i) its Certificate of Incorporation  or
Bylaws  (or  similar  governing documents), (ii) any  note,  bond,  mortgage,
indenture,  lease,  license,  contract,  agreement  or  other  instrument  or
obligation to which CIA or any of its subsidiaries is now a party or by which
any  of them or any of their respective properties or assets may be bound  or
(iii)  any  order, writ, injunction, decree, law, statute, rule or regulation
applicable to CIA, its subsidiaries or any of their respective properties  or
assets,  except  in  the  case of (ii) or (iii) for violations,  breaches  or
defaults  that  would not have a Material Adverse Effect on CIA.  Each  note,
bond,  mortgage,  indenture,  lease, license, contract,  agreement  or  other
instrument  or obligation to which CIA or any of its subsidiaries  is  now  a
party or by which any of them or any of their respective properties or assets
may  be  bound that is material to CIA and its subsidiaries taken as a  whole
and  that  has not expired is in full force and effect and is not subject  to
any  material default thereunder of which CIA is aware by any party obligated
to CIA or any subsidiary thereunder.

     Section  3.8. No Undisclosed Liabilities; Absence of Changes. Except  as
and  to  the  extent  disclosed  by CIA in  the  CIA,  none  of  CIA  or  its
subsidiaries had any liabilities or obligations of any nature, whether or not
accrued,  contingent  or  otherwise, that  would  be  required  by  generally
accepted  accounting  principles to be reflected on  a  consolidated  balance
sheet  of CIA and its consolidated subsidiaries (including the notes thereto)
or  which would have a Material Adverse Effect on CIA. Except as disclosed by
CIA,  none  of  CIA or its subsidiaries has incurred any liabilities  of  any
nature,  whether  or  not  accrued,  contingent  or  otherwise,  which  could
reasonably  be  expected to have, and there have been no events,  changes  or
effects  with  respect  to  CIA or its subsidiaries  having  or  which  could
reasonably be expected to have, a Material Adverse Effect on CIA.  Except  as
and to the extent disclosed by CIA there has not been (i) any material change
by  CIA  in  its accounting methods, principles or practices (other  than  as
required  after  the date hereof by concurrent changes in generally  accepted
accounting  principles), (ii) any revaluation by CIA of  any  of  its  assets
having  a Material Adverse Effect on CIA, including, without limitation,  any
write-down  of the value of any assets other than in the ordinary  course  of
business  or  (iii)  any other action or event that would have  required  the
consent  of any other party hereto pursuant to Section 4.2 of this  Agreement
had such action or event occurred after the date of this Agreement.

     Section 3.9. Litigation. Except as set forth in Schedule 3.9 of the  CIA
Disclosure   Schedule  there  is  no  suit,  claim,  action,  proceeding   or
investigation pending or, to the knowledge of CIA, threatened against CIA  or
any  of  its  subsidiaries or any of their respective  properties  or  assets
before any Governmental Entity which, individually or in the aggregate, could
reasonably  be  expected to have a Material Adverse Effect on  CIA  or  could
<PAGE>

reasonably  be  expected  to  prevent  or  delay  the  consummation  of   the
transactions contemplated by this Agreement. Except as disclosed by CIA, none
of  CIA  or  its  subsidiaries  is subject to any  outstanding  order,  writ,
injunction  or  decree which, insofar as can be reasonably  foreseen  in  the
future, could reasonably be expected to have a Material Adverse Effect on CIA
or  could reasonably be expected to prevent or delay the consummation of  the
transactions contemplated hereby.

     Section  3.10.  Compliance with Applicable Law. Except as  disclosed  by
CIA,  CIA  and  its  subsidiaries  hold  all  permits,  licenses,  variances,
exemptions,  orders and approvals of all Governmental Entities necessary  for
the lawful conduct of their respective businesses (the "CIA Permits"), except
for  failures  to hold such permits, licenses, variances, exemptions,  orders
and  approvals which would not have a Material Adverse Effect on CIA.  Except
as  disclosed  by  CIA, CIA and its subsidiaries are in compliance  with  the
terms  of  the CIA Permits, except where the failure so to comply  would  not
have  a  Material  Adverse Effect on CIA. Except as  disclosed  by  CIA,  the
businesses  of CIA and its subsidiaries are not being conducted in  violation
of any law, ordinance or regulation of any Governmental Entity except that no
representation  or  warranty is made in this Section  3.10  with  respect  to
Environmental Laws and except for violations or possible violations which  do
not, and, insofar as reasonably can be foreseen, in the future will not, have
a Material Adverse Effect on CIA. Except as disclosed by CIA no investigation
or  review by any Governmental Entity with respect to CIA or its subsidiaries
is  pending or, to the knowledge of CIA, threatened, nor, to the knowledge of
CIA,  has any Governmental Entity indicated an intention to conduct the same,
other than, in each case, those which CIA reasonably believes will not have a
Material Adverse Effect on CIA.

     Section 3.11. Employee Benefit Plans; Labor Matters.

     (a)  With  respect  to  each  employee benefit  plan,  program,  policy,
arrangement  and  contract  (including,  without  limitation,  any  "employee
benefit  plan,"  as  defined  in  Section  3(3)  of  ERISA),  maintained   or
contributed  to  at any time by CIA, any of its subsidiaries  or  any  entity
required  to  be aggregated with CIA or any of its subsidiaries  pursuant  to
Section  414 of the Code (each, a "CIA Employee Plan"), no event has occurred
and, to the knowledge of CIA, no condition or set of circumstances exists  in
connection  with  which CIA or any of its subsidiaries  could  reasonably  be
expected  to be subject to any liability which would have a Material  Adverse
Effect on CIA.

     (b) (i) No CIA Employee Plan is or has been subject to Title IV of ERISA
or  Section  412  of the Code; and (ii) each CIA Employee  Plan  intended  to
qualify  under Section 401(a) of the Code and each trust intended to  qualify
under  Section  501(a)  of the Code is the subject of  a  favorable  Internal
Revenue  Service determination letter, and nothing has occurred  which  could
reasonably be expected to adversely affect such determination.

     (c) Section 3.11(c) of the CIA Disclosure Schedule sets forth a true and
complete list, as of the date of this Agreement, of each person who holds any
CIA  Stock Options, together with the number of CIA Shares which are  subject
to  such  option, the date of grant of such option, the extent to which  such
option  is  vested  (or will become vested as a result of  the  Merger),  the
option price of such option (to the extent determined as of the date hereof),
whether  such option is a nonqualified stock option or is intended to qualify
as  an  incentive stock option within the meaning of Section  422(b)  of  the
Code,  and  the expiration date of such option. Section 3.11(c)  of  the  CIA
Disclosure Schedule also sets forth the total number of such incentive  stock
options and such nonqualified options. CIA has furnished COPSIL with complete
copies  of  the  plans pursuant to which the CIA Stock Options  were  issued.
Other  than the automatic vesting of CIA Stock Options that may occur without
any action on the part of CIA or its officers or directors, CIA has not taken
any  action  that  would result in any CIA Stock Options  that  are  unvested
becoming  vested  in  connection with or as a result  of  the  execution  and
delivery   of   this  Agreement  or  the  consummation  of  the  transactions
contemplated hereby.

     (d)  CIA has made available to COPSIL (i) a description of the terms  of
employment and compensation arrangements of all officers of CIA and a copy of
each  such agreement currently in effect; (ii) copies of all agreements  with
consultants  who are individuals obligating CIA to make annual cash  payments
in  an amount exceeding $60,000; (iii) a schedule listing all officers of CIA
who  have  executed a non-competition agreement with CIA and a copy  of  each
such  agreement  currently in effect; (iv) copies (or  descriptions)  of  all
severance  agreements, programs and policies of CIA with or relating  to  its
employees, except programs and policies required to be maintained by law; and
(v)  copies of all plans, programs, agreements and other arrangements of  the
CIA  with  or  relating  to  its employees which contain  change  in  control
provisions.
<PAGE>

     (e)  Except  as  disclosed  in Section 3.11(e)  of  the  CIA  Disclosure
Schedule   there  shall  be  no  payment,  accrual  of  additional  benefits,
acceleration  of payments, or vesting in any benefit under any  CIA  Employee
Plan or any agreement or arrangement disclosed under this Section 3.11 solely
by   reason   of  entering  into  or  in  connection  with  the  transactions
contemplated by this Agreement.

     (f)  There  are  no  controversies pending or, to the knowledge  of  CIA
threatened,  between  CIA  or  any  of its  subsidiaries  and  any  of  their
respective  employees,  which  controversies  have  or  could  reasonably  be
expected to have a Material Adverse Effect on CIA. Neither CIA nor any of its
subsidiaries is a party to any collective bargaining agreement or other labor
union  contract  applicable  to  persons  employed  by  CIA  or  any  of  its
subsidiaries (and neither CIA nor any of its subsidiaries has any outstanding
material  liability  with  respect  to any terminated  collective  bargaining
agreement  or  labor union contract), nor does CIA know of any activities  or
proceedings  of  any  labor  union to organize any  of  its  or  any  of  its
subsidiaries'  employees. CIA has no knowledge of any strike, slowdown,  work
stoppage, lockout or threat thereof by or with respect to any of its  or  any
of its subsidiaries' employees.

     Section 3.12. Environmental Laws and Regulations.

     (a) Except as disclosed by CIA, (i) each of CIA and its subsidiaries  is
in material compliance with all Environmental Laws, except for non-compliance
that  would  not  have  a  Material Adverse Effect on CIA,  which  compliance
includes,  but is not limited to, the possession by CIA and its  subsidiaries
of  all material permits and other governmental authorizations required under
applicable  Environmental Laws, and compliance with the terms and  conditions
thereof; (ii) none of CIA or its subsidiaries has received written notice of,
or,  to the knowledge of CIA, is the subject of, any Environmental Claim that
could  reasonably be expected to have a Material Adverse Effect on  CIA;  and
(iii) to the knowledge of CIA, there are no circumstances that are reasonably
likely to prevent or interfere with such material compliance in the future.

     (b)  Except as disclosed by CIA, there are no Environmental Claims which
could  reasonably be expected to have a Material Adverse Effect on  CIA  that
are pending or, to the knowledge of CIA, threatened against CIA or any of its
subsidiaries or, to the knowledge of CIA, against any person or entity  whose
liability for any Environmental Claim CIA or its subsidiaries has or may have
retained or assumed either contractually or by operation of law.

     Section  3.13. Tax Matters. Except as set forth in Section 3.13  of  the
CIA  Disclosure Schedule: (i) CIA and each of its subsidiaries has  filed  or
has  had  filed  on  its  behalf in a timely manner  (within  any  applicable
extension  periods) with the appropriate Governmental Entity all  income  and
other  material  Tax Returns with respect to Taxes of CIA  and  each  of  its
subsidiaries and all Tax Returns were in all material respects true, complete
and  correct;  (ii) all material Taxes with respect to CIA and  each  of  its
subsidiaries  have been paid in full or have been provided for in  accordance
with  GAAP  on CIA's most recent balance sheet which is part of the  CIA  SEC
Documents; (iii) there are no outstanding agreements or waivers extending the
statutory  period of limitations applicable to any federal, state,  local  or
foreign income or other material Tax Returns required to be filed by or  with
respect to CIA or its subsidiaries; (iv) to the knowledge of CIA none of  the
Tax Returns of or with respect to CIA or any of its subsidiaries is currently
being  audited or examined by any Governmental Entity; and (v) no  deficiency
for  any income or other material Taxes has been assessed with respect to CIA
or any of its subsidiaries which has not been abated or paid in full.

     Section  3.14. Title to Property. CIA and each of its subsidiaries  have
good  and  defensible title to all of their properties and assets,  free  and
clear  of all liens, charges and encumbrances except liens for taxes not  yet
due and payable and such liens or other imperfections of title, if any, as do
not materially detract from the value of or interfere with the present use of
the  property  affected thereby or which, individually or in  the  aggregate,
would not have a Material Adverse Effect on CIA; and, to CIA's knowledge, all
leases  pursuant  to which CIA or any of its subsidiaries lease  from  others
real  or  personal  property are in good standing,  valid  and  effective  in
accordance with their respective terms, and there is not, to the knowledge of
CIA,  under  any of such leases, any existing material default  or  event  of
default  (or  event  which  with notice or lapse  of  time,  or  both,  would
constitute  a material default and in respect of which CIA or such subsidiary
has not taken adequate steps to prevent such a default from occurring) except
where  the  lack  of such good standing, validity and effectiveness,  or  the
existence  of  such  default or event of default would not  have  a  Material
Adverse Effect on CIA.

<PAGE>

     Section 3.15. Intellectual Property.

     (a)  Each  of  CIA  and  its subsidiaries owns,  or  possesses  adequate
licenses or other valid rights to use, all existing United States and foreign
patents,  trademarks, trade names, services marks, copyrights, trade secrets,
and  applications  therefor that are material to its  business  as  currently
conducted (the "CIA Intellectual Property Rights").

     (b)  Except  as  set  forth in Section 3.15(b)  of  the  CIA  Disclosure
Schedule  the validity of the CIA Intellectual Property Rights and the  title
thereto of CIA or any subsidiary, as the case may be, is not being questioned
in any litigation to which CIA or any subsidiary is a party.

     (c)  The  conduct  of  the business of CIA and its subsidiaries  as  now
conducted  does  not,  to  CIA's  knowledge,  infringe  any  valid   patents,
trademarks,   tradenames,  service  marks  or  copyrights  of   others.   The
consummation of the transactions contemplated hereby will not result  in  the
loss or impairment of any CIA Intellectual Property Rights.

     (d)  Each  of  CIA  and  its subsidiaries has taken  steps  it  believes
appropriate  to  protect and maintain its trade secrets as  such,  except  in
cases where CIA has elected to rely on patent or copyright protection in lieu
of trade secret protection.

     Section  3.16.  Insurance.  CIA  and its subsidiaries  maintain  general
liability  and  other business insurance that CIA believes to  be  reasonably
prudent for its business.

     Section 3.17. Vote Required. The affirmative vote of the holders  of  at
least  a  majority  of the outstanding CIA Shares is the  only  vote  of  the
holders  of  any class or series of CIA's capital stock necessary to  approve
and adopt this Agreement and the Merger.

     Section  3.18. Tax Treatment. Neither CIA nor, to the knowledge of  CIA,
any  of  its  affiliates has taken or agreed to take any  action  that  would
prevent  the Merger from constituting a reorganization qualifying  under  the
provisions of Section 368(a) of the Code.

     Section  3.19.  Affiliates.  Except  for  the  directors  and  executive
officers of CIA, each of whom is listed in Section 3.19 of the CIA Disclosure
Schedule, there are no persons who, to the knowledge of CIA, may be deemed to
be  affiliates of CIA under Rule 1-02(b) of Regulation S-X of  the  SEC  (the
"CIA Affiliates").

     Section  3.20.  Certain Business Practices. None  of  CIA,  any  of  its
subsidiaries or any directors, officers, agents or employees of CIA or any of
its  subsidiaries  has (i) used any funds for unlawful contributions,  gifts,
entertainment or other unlawful expenses relating to political activity, (ii)
made  any  unlawful  payment to foreign or domestic government  officials  or
employees  or  to  foreign  or domestic political  parties  or  campaigns  or
violated any provision of the FCPA, or (iii) made any other unlawful payment.

     Section 3.21. Insider Interests. Except as set forth in Section 3.21  of
the  CIA  Disclosure Schedule, no officer or director of CIA has any interest
in any material property, real or personal, tangible or intangible, including
without  limitation,  any  computer software  or  CIA  Intellectual  Property
Rights,  used  in  or  pertaining to the business of CIA or  any  subsidiary,
except   for  the  ordinary  rights  of  a  stockholder  or  employee   stock
optionholder.

     Section 3.22. Opinion of Financial Adviser. No advisers, as of the  date
hereof, have delivered to the CIA Board a written opinion to the effect that,
as of such date, the exchange ratio contemplated by the Merger is fair to the
holders of CIA Shares.

     Section  3.23.  Brokers. No broker, finder or investment  banker  (other
than  the  CIA Financial Adviser, a true and correct copy of whose engagement
agreement has been provided to COPSIL) is entitled to any brokerage,  finders
or  other  fee or commission in connection with the transactions contemplated
by this Agreement based upon arrangements made by or on behalf of CIA.

     Section  3.24. Disclosure. No representation or warranty of CIA in  this
Agreement   or  any  certificate,  schedule,  document  or  other  instrument
furnished  or  to  be furnished to COPSIL pursuant hereto  or  in  connection
<PAGE>

herewith  contains,  as  of  the  date of such  representation,  warranty  or
instrument,  or will contain any untrue statement of a material fact  or,  at
the  date  thereof, omits or will omit to state a material fact necessary  to
make  any  statement  herein or therein, in light of the circumstances  under
which such statement is or will be made, not misleading.

     Section 3.25. No Existing Discussions. As of the date hereof, CIA is not
engaged, directly or indirectly, in any discussions or negotiations with  any
other  party  with  respect  to any Third Party Acquisition  (as  defined  in
Section 5.4).

     Section 3.26. Material Contracts.

     (a)  CIA  has  delivered  or otherwise made available  to  COPSIL  true,
correct  and  complete  copies  of  all contracts  and  agreements  (and  all
amendments,  modifications and supplements thereto and all  side  letters  to
which  CIA  is a party affecting the obligations of any party thereunder)  to
which  CIA  or  any of its subsidiaries is a party or by which any  of  their
properties or assets are bound that are, material to the business, properties
or  assets  of CIA and its subsidiaries taken as a whole, including,  without
limitation, to the extent any of the following are, individually  or  in  the
aggregate,  material to the business, properties or assets  of  CIA  and  its
subsidiaries  taken  as  a  whole, all: (i)  employment,  product  design  or
development,  personal  services,  consulting,  non-competition,   severance,
golden parachute or indemnification contracts (including, without limitation,
any  contract  to  which  CIA is a party involving employees  of  CIA);  (ii)
licensing,  publishing,  merchandising  or  distribution  agreements;   (iii)
contracts  granting  rights  of  first refusal  or  first  negotiation;  (iv)
partnership  or joint venture agreements; (v) agreements for the acquisition,
sale  or  lease of material properties or assets or stock or otherwise.  (vi)
contracts  or  agreements  with  any  Governmental  Entity;  and  (vii)   all
commitments  and agreements to enter into any of the foregoing (collectively,
together with any such contracts entered into in accordance with Section  5.2
hereof,  the 'CIA Contracts"). Neither CIA nor any of its subsidiaries  is  a
party to or bound by any severance, golden parachute or other agreement  with
any employee or consultant pursuant to which such person would be entitled to
receive any additional compensation or an accelerated payment of compensation
as a result of the consummation of the transactions contemplated hereby.

     (b)  Each  of  the CIA Contracts is valid and enforceable in  accordance
with  its  terms,  and there is no default under any CIA Contract  so  listed
either by CIA or, to the knowledge of CIA, by any other party thereto, and no
event  has  occurred that with the lapse of time or the giving of  notice  or
both  would  constitute a default thereunder by CIA or, to the  knowledge  of
CIA,  any other party, in any such case in which such default or event  could
reasonably be expected to have a Material Adverse Effect on CIA.

     (c) No party to any such CIA Contract has given notice to CIA of or made
a  claim against CIA with respect to any breach or default thereunder, in any
such  case  in which such breach or default could reasonably be  expected  to
have a Material Adverse Effect on CIA.

                                  ARTICLE 4

                                  Covenants

     Section  4.1.  Conduct of Business of COPSIL. Except as contemplated  by
this  Agreement  or  as  described in Section 4.1 of  the  COPSIL  Disclosure
Schedule,  during  the  period from the date hereof to  the  Effective  Time,
COPSIL  will  conduct  its  operations in the  ordinary  course  of  business
consistent  with past practice and, to the extent consistent therewith,  with
no  less  diligence and effort than would be applied in the absence  of  this
Agreement,  seek  to preserve intact its current business organization,  keep
available the service of its current officers and employees and preserve  its
relationships  with customers, suppliers and others having business  dealings
with  it  to the end that goodwill and ongoing businesses shall be unimpaired
at  the  Effective  Time. Without limiting the generality of  the  foregoing,
except  as otherwise expressly provided in this Agreement or as described  in
Section  4.1 of the COPSIL Disclosure Schedule, prior to the Effective  Time,
COPSIL will not, without the prior written consent of CIA:

     (a)  amend its Certificate of Incorporation or Bylaws (or other  similar
governing instrument);

     (b)  amend  the terms of any stock of any class or any other  securities
(except bank loans) or equity equivalents.

<PAGE>

     (c)  split,  combine  or  reclassify any shares of  its  capital  stock,
declare,  set  aside  or pay any dividend or other distribution  (whether  in
cash, stock or property or any combination thereof) in respect of its capital
stock,  make any other actual, constructive or deemed distribution in respect
of  its capital stock or otherwise make any payments to stockholders in their
capacity as such, or redeem or otherwise acquire any of its securities;

     (d)  adopt  a  plan  of  complete or partial  liquidation,  dissolution,
merger,    consolidation,    restructuring,   recapitalization    or    other
reorganization of COPSIL (other than the Merger);

     (e)  (i)  incur or assume any long-term or short-term debt or issue  any
debt securities except for borrowings or issuances of letters of credit under
existing  lines  of credit in the ordinary course of business;  (ii)  assume,
guarantee,  endorse  or  otherwise  become  liable  or  responsible  (whether
directly, contingently or otherwise) for the obligations of any other person.
(iii)  make  any loans, advances or capital contributions to, or  investments
in,  any  other person; (iv) pledge or otherwise encumber shares  of  capital
stock  of  COPSIL;  or  (v) mortgage or pledge any of  its  material  assets,
tangible  or  intangible,  or create or suffer to  exist  any  material  Lien
thereupon (other than tax Liens for taxes not yet due);

     (f)  except  as may be required by law, enter into, adopt  or  amend  or
terminate  any  bonus, profit sharing, compensation, severance,  termination,
stock  option, stock appreciation right, restricted stock, performance  unit,
stock  equivalent,  stock purchase agreement, pension,  retirement,  deferred
compensation,  employment,  severance or other  employee  benefit  agreement,
trust,  plan,  fund or other arrangement for the benefit or  welfare  of  any
director,  officer or employee in any manner, or increase in any  manner  the
compensation or fringe benefits of any director, officer or employee  or  pay
any  benefit not required by any plan and arrangement as in effect as of  the
date   hereof   (including,  without  limitation,  the  granting   of   stock
appreciation  rights  or  performance units); provided,  however,  that  this
paragraph  (f)  shall  not prevent COPSIL from (i) entering  into  employment
agreements or severance agreements with employees in the ordinary  course  of
business  and  consistent  with  past  practice  or  (ii)  increasing  annual
compensation  and/or  providing  for  or  amending  bonus  arrangements   for
employees  for  fiscal  1999 in the ordinary course of year-end  compensation
reviews  consistent with past practice and paying bonuses  to  employees  for
fiscal  1999 in amounts previously disclosed to CIA (to the extent that  such
compensation increases and new or amended bonus arrangements do not result in
a material increase in benefits or compensation expense to COPSIL);

     (g)  acquire,  sell,  lease  or dispose of  any  assets  in  any  single
transaction  or  series of related transactions (other than in  the  ordinary
course of business);

     (h)  except  as may be required as a result of a change  in  law  or  in
generally  accepted  accounting principles,  change  any  of  the  accounting
principles or practices used by it;

     (i) revalue in any material respect any of its assets including, without
limitation,  writing  down the value of inventory  or  writing-off  notes  or
accounts receivable other than in the ordinary course of business;

     (j)  (i)  acquire (by merger, consolidation, or acquisition of stock  or
assets)  any  corporation,  partnership or  other  business  organization  or
division thereof or any equity interest therein; (ii) enter into any contract
or  agreement  other than in the ordinary course of business consistent  with
past  practice  which would be material to COPSIL; (iii)  authorize  any  new
capital  expenditure  or expenditures which, individually  is  in  excess  of
$1,000 or, in the aggregate, are in excess of $5,000; provided, however  that
none  of  the foregoing shall limit any capital expenditure required pursuant
to existing contracts;

     (k)  make  any  tax  election  or settle or compromise  any  income  tax
liability material to COPSIL;

     (l) settle or compromise any pending or threatened suit, action or claim
which  (i)  relates  to  the transactions contemplated  hereby  or  (ii)  the
settlement  or  compromise of which could have a Material Adverse  Effect  on
COPSIL;

     (m)  commence any material research and development project or terminate
any  material research and development project that is currently ongoing,  in
either  case, except pursuant to the terms of existing contracts  or  in  the
ordinary course of business; or

<PAGE>

     (n)  take, or agree in writing or otherwise to take, any of the  actions
described  in Sections 4.1(a) through 4.1(m) or any action which  would  make
any  of  the  representations or warranties of  contained in  this  Agreement
untrue or incorrect.

     Section 4.2. Conduct of Business of CIA. Except as contemplated by  this
Agreement  or  as  described in Section 4.2 of the  CIA  Disclosure  Schedule
during  the  period  from  the date hereof to the Effective  Time,  CIA  will
conduct  its  operations in the ordinary course of business  consistent  with
past practice and, to the extent consistent therewith, with no less diligence
and  effort than would be applied in the absence of this Agreement,  seek  to
preserve intact its current business organization, keep available the service
of  its  current  officers and employees and preserve its relationships  with
customers, suppliers and others having business dealings with it to  the  end
that  goodwill  and ongoing businesses shall be unimpaired at  the  Effective
Time.  Without limiting the generality of the foregoing, except as  otherwise
expressly  provided in this Agreement or as described in Section 4.2  of  the
CIA  Disclosure Schedule, prior to the Effective Time, CIA will not,  without
the prior written consent of:

     (a)  amend its Certificate of Incorporation or Bylaws (or other  similar
governing instrument);

     (b)  authorize for issuance, issue, sell, deliver or agree or commit  to
issue,  sell or deliver (whether through the issuance or granting of options,
warrants,  commitments, subscriptions, rights to purchase or  otherwise)  any
stock  of  any  class or any other securities (except bank loans)  or  equity
equivalents  (including,  without limitation,  any  stock  options  or  stock
appreciation rights;

       (c)  split,  combine or reclassify any shares of  its  capital  stock,
declare,  set  aside  or pay any dividend or other distribution  (whether  in
cash, stock or property or any combination thereof) in respect of its capital
stock,  make any other actual, constructive or deemed distribution in respect
of  its capital stock or otherwise make any payments to stockholders in their
capacity as such, or redeem or otherwise acquire any of its securities;

     (d) adopt a plan of complete or partial liquidation, dissolution, merger
consolidation, restructuring, recapitalization or other reorganization of CIA
(other than the Merger);

     (e)  (i)  incur or assume any long-term or short-term debt or issue  any
debt securities except for borrowings or issuances of letters of credit under
existing  lines  of credit in the ordinary course of business.  (ii)  assume,
guarantee,  endorse  or  otherwise  become  liable  or  responsible  (whether
directly, contingently or otherwise) for the obligations of any other person;
(iii) make any loans, advances or capital contributions to or investments in,
any  other person; (iv) pledge or otherwise encumber shares of capital  stock
of  CIA  or  its subsidiaries; or (v) mortgage or pledge any of its  material
assets,  tangible  or intangible, or create or suffer to exist  any  material
Lien thereupon (other than tax Liens for taxes not yet due);

     (f)  except  as may be required by law, enter into, adopt  or  amend  or
terminate  any  bonus, profit sharing, compensation, severance,  termination,
stock  option,  stock appreciation right, restricted stock, performance  unit
stock  equivalent,  stock purchase agreement, pension,  retirement,  deferred
compensation,  employment,  severance or other  employee  benefit  agreement,
trust,  plan,  fund or other arrangement for the benefit or  welfare  of  any
director,  officer or employee in any manner, or increase in any  manner  the
compensation or fringe benefits of any director, officer or employee  or  pay
any  benefit not required by any plan and arrangement as in effect as of  the
date   hereof   (including,  without  limitation,  the  granting   of   stock
appreciation  rights  or  performance units); provided,  however,  that  this
paragraph  (f)  shall not prevent CIA or its subsidiaries from  (i)  entering
into  employment  agreements or severance agreements with  employees  in  the
ordinary  course  of  business and consistent  with  past  practice  or  (ii)
increasing  annual  compensation  and/or  providing  for  or  amending  bonus
arrangements for employees for fiscal 1999 in the ordinary course of  yearend
compensation  reviews  consistent with past practice and  paying  bonuses  to
employees for fiscal 1999 in amounts previously disclosed to  (to the  extent
that such compensation increases and new or amended bonus arrangements do not
result in a material increase in benefits or compensation expense to CIA);

     (g)  acquire,  sell,  lease  or dispose of  any  assets  in  any  single
transaction  or  series of related transactions other than  in  the  ordinary
course of business;

     (h)  except  as may be required as a result of a change  in  law  or  in
generally  accepted  accounting principles,  change  any  of  the  accounting
principles or practices used by it;

<PAGE>

     (i)  revalue  in  any  material respect any of  its  assets,  including,
without limitation, writing down the value of inventory of writing-off  notes
or accounts receivable other than in the ordinary course of business;

     (j)  (i)  acquire (by merger, consolidation, or acquisition of stock  or
assets)  any  corporation,  partnership, or other  business  organization  or
division thereof or any equity interest therein; (ii) enter into any contract
or  agreement  other than in the ordinary course of business consistent  with
past practice which would be material to CIA; (iii) authorize any new capital
expenditure or expenditures which, individually, is in excess of  $1,000  or,
in the aggregate, are in excess of $5,000: provided, however that none of the
foregoing  shall limit any capital expenditure required pursuant to  existing
contracts;

     (k)  make  any  tax  election  or settle or compromise  any  income  tax
liability material to CIA and its subsidiaries taken as a whole;

     (l) settle or compromise any pending or threatened suit, action or claim
which  (i)  relates  to  the transactions contemplated  hereby  or  (ii)  the
settlement  or  compromise of which could have a Material Adverse  Effect  on
CIA;

     (m)  commence any material research and development project or terminate
any  material research and development project that is currently ongoing,  in
either case, except pursuant to the terms of existing contracts or except  in
the ordinary course of business; or

     (n)  take, or agree in writing or otherwise to take, any of the  actions
described  in Sections 4.2(a) through 4.2(m) or any action which  would  make
any  of  the  representations or warranties of  the  CIA  contained  in  this
Agreement untrue or incorrect.

     Section 4.3. Preparation of 8-K and the Proxy Statement. CIA and   shall
promptly  prepare and file with the SEC the Proxy Statement, if  required  by
counsel.

     Section 4.4. Other Potential Acquirers.

     (a)  CIA,  its  affiliates  and  their respective  officers,  directors,
employees,  representatives and agents shall immediately cease  any  existing
discussions  or  negotiations, if any, with any parties conducted  heretofore
with respect to any Third Party Acquisition.

     Section 4.5. Meetings of Stockholders. Each of CIA and COPSIL shall take
all  action  necessary, in accordance with the respective General Corporation
Law  of its respective state, and its respective certificate of incorporation
and  bylaws, to duly call, give notice of, convene and hold a meeting of  its
stockholders  as  promptly  as practicable, to consider  and  vote  upon  the
adoption  and  approval  of this Agreement and the transactions  contemplated
hereby. The stockholder votes required for the adoption and approval  of  the
transactions contemplated by this Agreement shall be the vote required by the
NGCL  and  its  charter  and bylaws, in the case of COPSIL  and  the  General
Corporation Law of its respective state, and its charter and bylaws,  in  the
case  of  CIA.  COPSIL  and  CIA will, through  their  respective  Boards  of
Directors,  recommend  to  their  respective stockholders  approval  of  such
matters

     Section  4.6.  OTC:BB  Listing. The parties  shall  use  all  reasonable
efforts to cause the COPSIL Shares, subject to Rule 144, to be traded on  the
Over The Counter Bulletin Board (OTC:BB).

     Section 4.7. Access to Information.

     (a) Between the date hereof and the Effective Time, COPSIL will give CIA
and  its  authorized  representatives, and  CIA  will  give  COPSIL  and  its
authorized  representatives,  reasonable access  to  all  employees,  plants,
offices,  warehouses  and other facilities and to all books  and  records  of
itself  and  its  subsidiaries, will permit the  other  party  to  make  such
inspections as such party may reasonably require and will cause its  officers
and  those of its subsidiaries to furnish the other party with such financial
and  operating  data and other information with respect to the  business  and
properties of itself and its subsidiaries as the other party may from time to
time reasonably request.

<PAGE>

     (b) Between the date hereof and the Effective Time, COPSIL shall furnish
to CIA, and CIA will furnish to COPSIL, within 25 business days after the end
of  each  quarter, quarterly statements prepared by such party in  conformity
with its past practices) as of the last day of the period then ended.

     (c)  Each of the parties hereto will hold and will cause its consultants
and advisers to hold in confidence all documents and information furnished to
it in connection with the transactions contemplated by this Agreement.

     Section 4.8. Additional Agreements, Reasonable Efforts. Subject  to  the
terms  and  conditions herein provided, each of the parties hereto agrees  to
use all reasonable efforts to take, or cause to be taken, all action, and  to
do, or cause to be done, all things reasonably necessary, proper or advisable
under  applicable laws and regulations to consummate and make  effective  the
transactions  contemplated by this Agreement, including, without  limitation,
(i)  cooperating in the preparation and filing of the Proxy Statement and the
8-K,  any  filings that may be required under the HSR Act, and any amendments
to any thereof; (ii) obtaining consents of all third parties and Governmental
Entities  necessary,  proper  or  advisable  for  the  consummation  of   the
transactions  contemplated  by this Agreement;  (iii)  contesting  any  legal
proceeding  relating to the Merger and (iv) the execution of  any  additional
instruments  necessary  to consummate the transactions  contemplated  hereby.
Subject  to the terms and conditions of this Agreement, CIA and COPSIL  agree
to use all reasonable efforts to cause the Effective Time to occur as soon as
practicable after the stockholder votes with respect to the Merger.  In  case
at any time after the Effective Time any further action is necessary to carry
out the purposes of this Agreement, the proper officers and directors of each
party hereto shall take all such necessary action.

     Section  4.9.  Employee  Benefits; Stock Option  and  Employee  Purchase
Plans.  Subject  to  the provisions of Section 1.6(d) hereof,  prior  to  the
Effective Time, COPSIL will take or cause to be taken all action necessary to
adopt  and or revise the employment agreements of Ralph Massetti with COPSIL.
It  is  the  parties' present intent to provide after the Effective  Time  to
employees  of  CIA employee benefit plans (other than stock option  or  other
plans involving the potential issuance of securities of COPSIL) which, in the
aggregate,  are  not  less favorable than those currently  provided  by  CIA.
Notwithstanding the foregoing, nothing contained herein shall be construed as
requiring the parties to continue any specific employee benefit plans.

     Section  4.10. Public Announcements. CIA, and COPSIL will  consult  with
one  another before issuing any press release or otherwise making any  public
statements  with respect to the transactions contemplated by this  Agreement,
including, without limitation, the Merger, and shall not issue any such press
release or make any such public statement prior to such consultation,  except
as  may  be  required  by applicable law or by obligations  pursuant  to  any
listing  agreement with the NASD Over The Counter Bulletin Board (OTC:BB)  as
determined by CIA or COPSIL.

     Section 4.11. Indemnification.

     (a)  To the extent, if any, not provided by an existing right under  one
of the parties' directors and officers liability insurance policies, from and
after  the  Effective Time, COPSIL shall, to the fullest extent permitted  by
applicable law, indemnify, defend and hold harmless each person who  is  now,
or has been at any time prior to the date hereof, or who becomes prior to the
Effective Time, a director, officer or employee of the parties hereto or  any
subsidiary  thereof  (each  an  "Indemnified Party"  and,  collectively,  the
''Indemnified  Parties") against all losses, expenses  (including  reasonable
attorneys' fees and expenses), claims, damages or liabilities or, subject  to
the  proviso  of  the  next succeeding sentence, amounts paid  in  settlement
arising  out  of actions or omissions occurring at or prior to the  Effective
Time  and  whether  asserted or claimed prior to, at or after  the  Effective
Time)  that are in whole or in part (i) based on, or arising out of the  fact
that such person is or was a director, officer or employee of such party or a
subsidiary  of  such party or (ii) based on, arising out of or pertaining  to
the  transactions contemplated by this Agreement. In the event  of  any  such
loss  expense, claim, damage or liability (whether or not arising before  the
Effective  Time), (i) COPSIL shall pay the reasonable fees  and  expenses  of
counsel  selected  by  the  Indemnified  Parties,  which  counsel  shall   be
reasonably  satisfactory  to COPSIL, promptly after statements  therefor  are
received  and  otherwise  advance  to such  Indemnified  Party  upon  request
reimbursement of documented expenses reasonably incurred, in either  case  to
the extent not prohibited by the NGCL or its certificate of incorporation  or
bylaws,  (ii)  COPSIL will cooperate in the defense of any  such  matter  and
(iii)  any  determination  required to be made with  respect  to  whether  an
Indemnified Party's conduct complies with the standards set forth  under  the
NGCL  and  COPSIL's certificate of incorporation or bylaws shall be  made  by
<PAGE>

independent counsel mutually acceptable to COPSIL and the Indemnified  Party;
provided,  however,  that  COPSIL shall not  be  liable  for  any  settlement
effected without its written consent (which consent shall not be unreasonably
withheld).  The Indemnified Parties as a group may retain only one  law  firm
with  respect to each related matter except to the extent there  is,  in  the
opinion  of  counsel to an Indemnified Party, under applicable  standards  of
professional  conduct, c conflict on any significant issue between  positions
of any two or more Indemnified Parties.

       (b)  In  the  event  COPSIL or any of its successors  or  assigns  (i)
consolidates  with  or  merges into any other person and  shall  not  be  the
continuing or surviving corporation or entity or such consolidation or merger
or  (ii)  transfers all or substantially all of its properties and assets  to
any  person, then and in either such case, proper provision shall be made  so
that  the  successors and assigns of COPSIL shall assume the obligations  set
forth in this Section 4.11.

     (c) To the fullest extent permitted by law, from and after the Effective
Time,  all  rights to indemnification now existing in favor of the employees,
agents,  directors or officers of COPSIL and CIA and their subsidiaries  with
respect  to their activities as such prior to the Effective Time, as provided
in  COPSIL's and CIA's certificate of incorporation or bylaws, in  effect  on
the date thereof or otherwise in effect on the date hereof, shall survive the
Merger  and shall continue in full force and effect for a period of not  less
than six years from the Effective Time.

     (d)  The  provisions of this Section 4.11 are intended  to  be  for  the
benefit of, and shall be enforceable by, each Indemnified Party, his  or  her
heirs and his or her representatives.

     Section 4.12. Notification of Certain Matters. The parties hereto  shall
give  prompt  notice  to  the  other  parties,  of  (i)  the  occurrence   or
nonoccurrence of any event the occurrence or nonoccurrence of which would  be
likely to cause any representation or warranty contained in this Agreement to
be  untrue or inaccurate in any material respect at or prior to the Effective
Time,  (ii) any material failure of such party to comply with or satisfy  any
covenant,  condition  or agreement to be complied with  or  satisfied  by  it
hereunder, (iii) any notice of, or other communication relating to, a default
or event which, with notice or lapse of time or both, would become a default,
received by such party or any of its subsidiaries subsequent to the  date  of
this  Agreement  and  prior  to the Effective Time,  under  any  contract  or
agreement  material  to  the financial condition, properties,  businesses  or
results of operations of such party and its subsidiaries taken as a whole  to
which  such  party or any of its subsidiaries is a party or is subject,  (iv)
any  notice  or  other communication from any third party alleging  that  the
consent  of  such  third party is or may be required in connection  with  the
transactions  contemplated by this Agreement, or  (v)  any  material  adverse
change  in  their  respective  financial condition,  properties,  businesses,
results  of  operations  or prospects taken as a whole,  other  than  changes
resulting  from  general  economic conditions; provided,  however,  that  the
delivery  of  any notice pursuant to this Section 4.12 shall  not  cure  such
breach  or non-compliance or limit or otherwise affect the remedies available
hereunder to the party receiving such notice.

                                  ARTICLE 5

                  Conditions to Consummation of the Merger

     Section  5.1.  Conditions  to Each Party's  Obligations  to  Effect  the
Merger. The respective obligations of each party hereto to effect the  Merger
are  subject  to the satisfaction at or prior to the Effective  Time  of  the
following conditions:

     (a) this Agreement shall have been approved and adopted by the requisite
vote of the stockholders of COPSIL and CIA;

     (b) this Agreement shall have been approved and adopted by the Board  of
Directors of COPSIL and CIA;

     (c)  no  statute, rule, regulation, executive order, decree,  ruling  or
injunction shall have been enacted, entered, promulgated or enforced  by  any
United  States court or United States governmental authority which prohibits,
restrains, enjoins or restricts the consummation of the Merger;
<PAGE>

     (d)  any waiting period applicable to the Merger under the HSR Act shall
have  terminated or expired, and any other governmental or regulatory notices
or  approvals  required with respect to the transactions contemplated  hereby
shall have been either filed or received; and

     Section 5.2. Conditions to the Obligations of COPSIL. The obligation  of
COPSIL to effect the Merger is subject to the satisfaction at or prior to the
Effective Time of the following conditions:

     (a)  the  representations of CIA contained in this Agreement or  in  any
other document delivered pursuant hereto shall be true and correct (except to
the  extent that the breach thereof would not have a Material Adverse  Effect
on  CIA)  at and as of the Effective Time with the same effect as if made  at
and  as  of  the  Effective Time (except to the extent  such  representations
specifically  related to an earlier date, in which case such  representations
shall  be  true and correct as of such earlier date), and at the Closing  CIA
shall have delivered to COPSIL a certificate to that effect;

     (b)  each of the covenants and obligations of CIA to be performed at  or
before the Effective Time pursuant to the terms of this Agreement shall  have
been  duly performed in all material respects at or before the Effective Time
and  at the Closing CIA shall have delivered to COPSIL a certificate to  that
effect;

       (d)  CIA  shall have obtained the consent or approval of  each  person
whose consent or approval shall be required in order to permit the Merger, as
relates to any obligation, right or interest of CIA under any loan or  credit
agreement, note, mortgage, indenture, lease or other agreement or instrument,
except  those  for which failure to obtain such consents and approvals  would
not,  in  the reasonable opinion of COPSIL, individually or in the aggregate,
have a Material Adverse Effect on CIA;

     (e) there shall have been no events, changes or effects with respect  to
CIA  or its subsidiaries having or which could reasonably be expected to have
a Material Adverse Effect on CIA; and

     Section  5.3.  Conditions  to the Obligations  of  CIA.  The  respective
obligations of CIA to effect the Merger are subject to the satisfaction at or
prior to the Effective Time of the following conditions:

     (a)  the representations of COPSIL contained in this Agreement or in any
other document delivered pursuant hereto shall be true and correct (except to
the  extent that the breach thereof would not have a Material Adverse  Effect
on COPSIL) at and as of the Effective Time with the same effect as if made at
and  as  of  the  Effective Time (except to the extent  such  representations
specifically  related to an earlier date, in which case such  representations
shall be true and correct as of such earlier date), and at the Closing COPSIL
shall have delivered to CIA a certificate to that effect;

     (b)  each of the covenants and obligations of COPSIL to be performed  at
or  before  the Effective Time pursuant to the terms of this Agreement  shall
have  been duly performed in all material respects at or before the Effective
Time  and at the Closing COPSIL shall have delivered to CIA a certificate  to
that effect;

     (c) there shall have been no events, changes or effects with respect  to
COPSIL  having  or  which could reasonably be expected  to  have  a  Material
Adverse Effect on COPSIL.

                                  ARTICLE 6

                       Termination; Amendment; Waiver

     Section  6.1.  Termination. This Agreement may  be  terminated  and  the
Merger  may  be  abandoned at any time prior to the Effective  Time,  whether
before or after approval and adoption of this Agreement by COPSIL's or  CIA's
stockholders:

     (a) by mutual written consent of COPSIL and CIA;

     (b)  by CIA or COPSIL if (i) any court of competent jurisdiction in  the
United States or other United States Governmental Entity shall have issued  a
<PAGE>

final  order,  decree or ruling or taken any other final action  restraining,
enjoining or otherwise prohibiting the Merger and such order, decree,  ruling
or  other action is or shall have become nonappealable or (ii) the Merger has
not  been  consummated by June 1, 2000; provided, however, that no party  may
terminate this Agreement pursuant to this clause (ii) if such party's failure
to  fulfill any of its obligations under this Agreement shall have  been  the
reason  that  the Effective Time shall not have occurred on  or  before  said
date;

     (c)   by  COPSIL  if  (i)  there  shall  have  been  a  breach  of   any
representation or warranty on the part of CIA set forth in this Agreement, or
if  any representation or warranty of CIA shall have become untrue, in either
case  such that the conditions set forth in Section 5.2(a) would be incapable
of  being  satisfied by June 1, 2000 (or as otherwise extended),  (ii)  there
shall  have  been  a  breach by CIA of any of their respective  covenants  or
agreements  hereunder having a Material Adverse Effect on CIA  or  materially
adversely affecting (or materially delaying) the consummation of the  Merger,
and  CIA,  as  the case may be, has not cured such breach within 20  business
days  after  notice by COPSIL thereof, provided that COPSIL has not  breached
any  of its obligations hereunder, (iii) COPSIL shall have convened a meeting
of  its  stockholders to vote upon the Merger and shall have failed to obtain
the requisite vote of its stockholders; or (iv) COPSIL shall have convened  a
meeting  of  its  Board of Directors to vote upon the Merger and  shall  have
failed to obtain the requisite vote;

     (d)  by  CIA if (i) there shall have been a breach of any representation
or  warranty  on the part of COPSIL set forth in this Agreement,  or  if  any
representation or warranty of COPSIL shall have become untrue, in either case
such  that  the conditions set forth in Section 5.3(a) would be incapable  of
being  satisfied by June 1, 2000 (or as otherwise extended), (ii) there shall
have  been a breach by COPSIL of its covenants or agreements hereunder having
a  Material  Adverse Effect on COPSIL or materially adversely  affecting  (or
materially delaying) the consummation of the Merger, and COPSIL, as the  case
may be, has not cured such breach within twenty business days after notice by
CIA  thereof,  provided  that CIA has not breached  any  of  its  obligations
hereunder,  (iii)  the  COPSIL  Board  shall  have  recommended  to  COPSIL's
stockholders a Superior Proposal, (iv) the COPSIL Board shall have withdrawn,
modified or changed its approval or recommendation of this Agreement  or  the
Merger  or  shall  have failed to call, give notice of,  convene  or  hold  a
stockholders'  meeting  to vote upon the Merger, or shall  have  adopted  any
resolution  to  effect any of the foregoing, (v) CIA shall  have  convened  a
meeting of its stockholders to vote upon the Merger and shall have failed  to
obtain  the  requisite  vote of its stockholders or (vi)  COPSIL  shall  have
convened a meeting of its stockholders to vote upon the Merger and shall have
failed to obtain the requisite vote of its stockholders.

     Section 6.2. Effect of Termination. In the event of the termination  and
abandonment  of this Agreement pursuant to Section 6.1, this Agreement  shall
forthwith become void and have no effect, without any liability on  the  part
of  any  party hereto or its affiliates, directors, officers or stockholders,
other  than  the provisions of this Section 6.2 and Sections 4.7(c)  and  6.3
hereof.  Nothing contained in this Section 6.2 shall relieve any  party  from
liability for any breach of this Agreement.

     Section 6.3. Fees and Expenses. Except as specifically provided in  this
Section  6.3, each party shall bear its own expenses in connection with  this
Agreement and the transactions contemplated hereby.

     Section 6.4. Amendment. This Agreement may be amended by action taken by
COPSIL  and  CIA at any time before or after approval of the  Merger  by  the
stockholders of COPSIL and CIA (if required by applicable law) but, after any
such approval, no amendment shall be made which requires the approval of such
stockholders  under applicable law without such approval. This Agreement  may
not  be  amended except by an instrument in writing signed on behalf  of  the
parties hereto.

     Section 6.5. Extension; Waiver. At any time prior to the Effective Time,
each  party hereto may (i) extend the time for the performance of any of  the
obligations or other acts of any other party, (ii) waive any inaccuracies  in
the representations and warranties of any other party contained herein or  in
any document, certificate or writing delivered pursuant hereto or (iii) waive
compliance  by  any  other  party with any of the  agreements  or  conditions
contained herein. Any agreement on the part of any party hereto to  any  such
extension  or  waiver shall be valid only if set forth in  an  instrument  in
writing  signed on behalf of such party. The failure of any party  hereto  to
assert  any  of  its rights hereunder shall not constitute a waiver  of  such
rights.
<PAGE>

                                  ARTICLE 7

                                Miscellaneous

     Section   7.1.  Nonsurvival  of  Representations  and  Warranties.   The
representations  and  warranties made herein shall  not  survive  beyond  the
Effective Time or a termination of this Agreement. This Section 7.1 shall not
limit  any  covenant or agreement of the parties hereto which  by  its  terms
requires performance after the Effective Time.

     Section   7.2.   Entire  Agreement;  Assignment.  This   Agreement   (a)
constitutes the entire agreement between the parties hereto with  respect  to
the  subject  matter  hereof and supersedes all other  prior  agreements  and
understandings both written and oral, between the parties with respect to the
subject  matter hereof and (b) shall not be assigned by operation of  law  or
otherwise.

     Section  7.3.  Validity.  If any provision of  this  Agreement,  or  the
application  thereof  to  any  person or circumstance,  is  held  invalid  or
unenforceable, the remainder of this Agreement, and the application  of  such
provision  to other persons or circumstances, shall not be affected  thereby,
and to such end, the provisions of this Agreement are agreed to be severable.

     Section  7.4. Notices. All notices, requests, claims, demands and  other
communications hereunder shall be in writing and shall be given (and shall be
deemed  to  have  been  duly given upon receipt) by delivery  in  person,  by
facsimile or by registered or certified mail (postage prepaid, return receipt
requested), to each other party as follows:

  If to CIA:

     Cochstedt International Airport, Inc.
     6170 W. Desert Inn Rd.
     Las Vegas, Nevada 89146
<PAGE>

  with a copy to:

     Donald J. Stoecklein
     Sperry Young & Stoecklein
     1850 East Flamingo Rd. Suite 111
     Las Vegas, Nevada 89119
     (702) 792-2590
     (702) 794-0744

  if to COPSIL:

     COPSIL CORPORATION
     7621 Genzer Drive
     Las Vegas, Nevada 89128


or  to  such  other address as the person to whom notice is  given  may  have
previously furnished to the others in writing in the manner set forth above.

     Section  7.5.  Governing Law. This Agreement shall be  governed  by  and
construed in accordance with the laws of the State of Nevada, without  regard
to the principles of conflicts of law thereof.

     Section  7.6. Descriptive Headings. The descriptive headings herein  are
inserted for convenience of reference only and are not intended to be part of
or to affect the meaning or interpretation of this Agreement.

     Section  7.7. Parties in Interest. This Agreement shall be binding  upon
and  inure solely to the benefit of each party hereto and its successors  and
permitted  assigns, and except as provided in Sections 4.9 and 4.11,  nothing
in  this  Agreement, express or implied, is intended to or shall confer  upon
any  other  person any rights, benefits or remedies of any nature  whatsoever
under or by reason of this Agreement.

     Section  7.8.  Certain Definitions. For the purposes of this  Agreement,
the term:

     (a)  "affiliate" means (except as otherwise provided in  Sections  2.19,
3.19  and  4.13) a person that directly or indirectly, through  one  or  more
intermediaries, controls, is controlled by, or is under common control  with,
the first mentioned person;

     (b)  "business  day" means any day other than a day on which  Nasdaq  is
closed;

     (c)  "capital  stock" means common stock, preferred  stock,  partnership
interests,  limited liability company interests or other ownership  interests
entitling  the  holder thereof to vote with respect to matters involving  the
issuer thereof;

     (d)  "knowledge''  or  "known'' means, with respect  to  any  matter  in
question,  if  an executive officer of COPSIL or CIA or its subsidiaries,  as
the case may be, has actual knowledge of such matter;

     (e)  "person"  means  an individual, corporation,  partnership,  limited
liability company, association, trust, unincorporated organization  or  other
legal entity; and

     (f)  "subsidiary" or "subsidiaries" of COPSIL, CIA or any other  person,
means  any  corporation, partnership, limited liability company, association,
trust, unincorporated association or other legal entity of which COPSIL,  CIA
or  any  such  other person, as the case may be (either alone or  through  or
together  with  any other subsidiary), owns, directly or indirectly,  50%  or
more  of  the  capital stock, the holders of which are generally entitled  to
vote  for the election of the board of directors or other governing  body  of
such corporation or other legal entity.

<PAGE>

     Section 7.9. Personal Liability. This Agreement shall not create  or  be
deemed  to create or permit any personal liability or obligation on the  part
of  any  direct  or  indirect stockholder of COPSIL or CIA  or  any  officer,
director, employee, agent, representative or investor of any party hereto.

     Section  7.10. Specific Performance. The parties hereby acknowledge  and
agree  that the failure of any party to perform its agreements and  covenants
hereunder, including its failure to take all actions as are necessary on  its
part to the consummation of the Merger, will cause irreparable injury to  the
other  parties for which damages, even if available, will not be an  adequate
remedy. Accordingly, each party hereby consents to the issuance of injunctive
relief  by any court of competent jurisdiction to compel performance of  such
party's  obligations  and  to the granting by any  court  of  the  remedy  of
specific  performance of its obligations hereunder; provided, however,  that,
if  a  party  hereto is entitled to receive any payment or  reimbursement  of
expenses pursuant to Sections 6.3(a), (b) or (c), it shall not be entitled to
specific performance to compel the consummation of the Merger.

     Section  7.11. Counterparts. This Agreement may be executed  in  one  or
more  counterparts, each of which shall be deemed to be an original, but  all
of which shall constitute one and the same agreement.

In  Witness Whereof, each of the parties has caused this Agreement to be duly
executed on its behalf as of the day and year first above written.
                                   Cochstedt International Airport, Inc.

                                   By:/s/ Friedrich Gradl
                                    Name: Friedrich Gradl
                                    Title: President

                                   Copsil Corporation

                                   By:/s/ Debra Nicholson
                                    Name: Debra Nicholson
                                    Title: President
<PAGE>


                         COPSIL DISCLOSURE SCHEDULE
Schedule      2.1        Organization                       See       Amended
Articles/Bylaws/Minutes

Schedule 2.6   Consents & Approvals          None Required

Schedule 2.7   No Default                    Not Applicable

Schedule 2.8   No Undisclosed Liability      None Exist

Schedule 2.9   Litigation                    None Exist

Schedule  2.10   Compliance with Applicable Law      Not  Applicable  -  full
disclosed in 10KSB

Schedule 2.11 Employee Benefit Plans         Section 2.11(a) Not Applicable -
None Exist

                                   Section 2.11(b) No Benefit Plan Exist

                                   Section 2.11( c)No Options Exist

                                   Section 2.11(d) No Agreements Exist

Schedule 2.12 Environmental Laws and Regs    Not Applicable

Schedule 2.13 Tax Matters                    None Exist

Schedule 2.14 Title to Property              None Exist

Schedule 2.15 Intellectual Property               None Exist

Schedule 2.16 Insurance                 None Exist

Schedule   2.17    Vote  Required                  See  Shareholder   Meeting
Certificate

Schedule 2.18 Tax Treatment                  Not Applicable

Schedule 2.19 Affiliates                Debra Nicholson

Schedule 2.20 Certain Business Practices          None Exist

Schedule 2.21 Insider Interest                    None Exist

Schedule 2.22 Opinion of Financial Adviser        Waived - None Exist

Schedule 2.23 Broker                         None Exist

Schedule 4.1 Conduct of Business             See Amended & Restated Articles

<PAGE>

                           CIA DISCLOSURE SCHEDULE
Schedule 3.2(b) Subsidiary Stock             None Exist

Schedule 3.2(c) Capital Stock Rights              None Exist other than as in
Articles

Schedule 3.2(d) Securities conversions       None Exist

Schedule 3.2 (f) Subsidiaries                None Exist

Schedule 3.6   Consents & Approvals          None Required

Schedule 3.7   No Default                    Not Applicable

Schedule 3.8   No Undisclosed Liability      None Exist

Schedule 3.9   Litigation                    None Exist

Schedule 3.10  Compliance with Applicable Law     Not Applicable

Schedule 3.11 Employee Benefit Plans         Section 3.11( c)No Options Exist

                                   Section 3.11(e) No Agreements Exist

Schedule 3.12 Environmental Laws and Regs    Not Applicable

Schedule 3.13 Tax Matters                    None Exist

Schedule 3.14 Title to Property              None Exist

Schedule 3.15(b) Intellectual Property       None Exist

Schedule 3.16 Insurance                 None Exist

Schedule   3.17    Vote  Required                  See  Shareholder   Meeting
Certificate

Schedule 3.18 Tax Treatment                  Not Applicable

Schedule 3.19 Affiliates                Friedrich Gradl
                                   Jorg Bartholomaus
                                   Norbert Doerr

Schedule 3.20 Certain Business Practices          None Exist

Schedule 3.21 Insider Interest                    None Exist

Schedule 3.22 Opinion of Financial Adviser        Waived - None Exist

<PAGE>
Schedule 2.23 Broker                         None Exist

Schedule 4.2 Conduct of Business             See Amended & Restated Articles



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission